WO2019078327A1 - Inflammation evaluation system, evaluation method, program, and non-transient recording medium - Google Patents

Inflammation evaluation system, evaluation method, program, and non-transient recording medium Download PDF

Info

Publication number
WO2019078327A1
WO2019078327A1 PCT/JP2018/038931 JP2018038931W WO2019078327A1 WO 2019078327 A1 WO2019078327 A1 WO 2019078327A1 JP 2018038931 W JP2018038931 W JP 2018038931W WO 2019078327 A1 WO2019078327 A1 WO 2019078327A1
Authority
WO
WIPO (PCT)
Prior art keywords
value
evaluation
measurement
erythema
inflammation
Prior art date
Application number
PCT/JP2018/038931
Other languages
French (fr)
Japanese (ja)
Inventor
晃久 奥谷
潤一 牛場
幸治 森川
幹生 岩川
Original Assignee
パナソニック株式会社
学校法人慶應義塾
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by パナソニック株式会社, 学校法人慶應義塾 filed Critical パナソニック株式会社
Priority to JP2019549357A priority Critical patent/JP6917600B2/en
Publication of WO2019078327A1 publication Critical patent/WO2019078327A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/107Measuring physical dimensions, e.g. size of the entire body or parts thereof

Definitions

  • the present disclosure relates to an inflammation evaluation system, an evaluation method, a program, and a non-temporary recording medium, and more specifically, an evaluation system, an evaluation method, a program, and a non-temporary for evaluating the degree of inflammation generated in human skin. Recording medium.
  • Erythema is a rash name that refers to the redness (redness) of the epidermis caused by capillary dilation or hyperemia of the dermis.
  • Patent Document 1 describes an example of an evaluation method for evaluating the degree of such inflammation (erythema).
  • the evaluation method described in Patent Document 1 measures the light reflectance of a skin area or a mucous membrane area in which erythema has occurred, and acquires L * value and a * value of the measurement result according to L * a * b * color space.
  • the erythema value is calculated by substituting the obtained value into the equation (L * max ⁇ L *) ⁇ a *.
  • the presence or absence of inflammation and the degree of inflammation are evaluated based on the calculated erythema value.
  • the erythema value when measuring the erythema value, it is necessary to bring the device for measurement into contact with the skin, but the hair present in the epidermis intervenes between the device for measurement and the epidermis, and the erythema value is measured by the influence of the body hair Errors can increase. As the measurement error of the erythema value increases, the accuracy of the evaluation of inflammation also decreases.
  • An object of the present disclosure is to provide an inflammation evaluation system, an evaluation method, a program, and a non-temporary recording medium capable of suppressing reduction in accuracy of evaluation.
  • An inflammation evaluation system is an evaluation system that evaluates inflammation generated in the skin.
  • the evaluation system acquires an acquisition unit that acquires a measurement value including an intensity value of a color different from the erythema value and the color of the erythema at the measurement site of the skin measured by a measuring instrument, and the plurality of measurements acquired by the acquisition unit And an evaluation unit that evaluates inflammation based on the erythema value included in the value.
  • the evaluation unit compares the erythema value and the intensity value in each of the plurality of measurement values, and compares the erythema value and the intensity value in the comparison with each other, and the measurement value is within a predetermined range as an evaluation candidate Elect to be a measured value.
  • the evaluation unit evaluates inflammation based on the erythema value included in the measurement value of the evaluation candidate.
  • the evaluation method is an evaluation method for evaluating inflammation generated in the skin.
  • a measurement value including an intensity value of a color different from the color of the erythema and the color of the erythema at the measurement site of the skin measured by a measuring device is obtained, Compare intensity values.
  • a measurement value in which the ratio of the erythema value and the intensity value compared is within a predetermined range is selected as the measurement value of the evaluation candidate, and the erythema value included in the measurement value of the evaluation candidate is selected.
  • a program according to an aspect of the present disclosure causes a computer system to execute the evaluation method.
  • the non-temporary recording medium is a computer system-readable non-temporary recording medium in which a program for causing a computer system to execute a method of evaluating a brain activity measuring device is recorded.
  • FIG. 1 shows a state of use of an electroencephalogram measurement system including a headset mounted on the head of a subject who is a subject of evaluation of an inflammation evaluation system according to an embodiment of the present disclosure, and a rehabilitation support system including the same.
  • FIG. FIG. 2 is a block diagram showing the configuration of the above-mentioned electroencephalogram measurement system and rehabilitation support system.
  • FIG. 3A is a schematic top view showing the usage state of the above headset.
  • FIG. 3B is a schematic front view showing the usage state of the above headset.
  • FIG. 4 is a system configuration diagram of the above evaluation system.
  • FIG. 5 is a flowchart for explaining the operation of the evaluation system of the same.
  • FIG. 6 is a flowchart for explaining the operation of the evaluation system of the same.
  • FIG. 7 is an explanatory diagram for explaining measurement values in the evaluation system of the same.
  • FIG. 8 is a diagram showing a line graph for explaining the operation of the evaluation system of the same.
  • the inflammation to be evaluated is, for example, inflammation caused by wearing a brain activity measuring apparatus (hereinafter referred to as a headset 1) on the head.
  • the headset 1 constitutes an electroencephalogram measurement system 10 together with an information processing apparatus 2 as shown in FIG.
  • the electroencephalogram measurement system 10 is a system for measuring the electroencephalogram of the subject 5, and the electroencephalogram from the electrode unit 11 disposed at a position corresponding to the measurement point 51 which is a part of the head 52 of the subject 5 Get information.
  • the term “electroencephalogram (EEG)” as referred to in the present disclosure means a waveform obtained by extruding an electrical signal (action potential) emitted from a cerebral nerve cell (group) and recording it.
  • the electroencephalogram measurement system 10 includes a headset 1 (see FIG. 3B) having an electrode unit 11 and an information processing device 2.
  • the headset 1 is mounted on the head 52 of the subject 5 with the electrode unit 11 in contact with the surface (scalp) of the head 52 of the subject 5.
  • the electrode unit 11 contacts the surface of the head 52 by being placed on the paste (electrode paste) applied to the surface of the head 52.
  • the electrode unit 11 contacts the surface of the head 52 without the hair by scraping the hair.
  • the electrode unit 11 may be in direct contact with the surface of the head 52 without applying a paste.
  • contacting the electrode unit 11 with the surface of the head 52 refers to contacting the electrode unit 11 directly with the surface of the head 52 (including the scalp) or via an intermediate. It also includes bringing the electrode portion 11 into contact with the surface of the head 52 indirectly.
  • the intermediate is not limited to the paste, and may be, for example, a gel having conductivity.
  • the headset 1 measures the brain waves of the subject 5 by measuring the action potential of the brain of the subject 5 with the electrode unit 11, and generates brain wave information representing the brain waves.
  • the headset 1 transmits brain wave information to the information processing apparatus 2 by wireless communication, for example.
  • the information processing apparatus 2 mainly includes, for example, a computer system such as a personal computer.
  • the information processing apparatus 2 receives brain wave information from the headset 1 by wireless communication, for example, performs various processes on the brain wave information acquired from the headset 1, and displays the brain wave information.
  • detection of an electroencephalogram including characteristic changes that occur when the subject 5 performs a voluntary movement that is, can occur when the subject 5 intends to perform a voluntary exercise
  • the calibration process and the like are performed by the information processing apparatus 2.
  • the “calibration process” in the present disclosure is a process for analyzing brain wave information, that is, for determining various parameters used for detection of a brain wave to be detected.
  • the headset 1 includes a frame 17, an attachment portion 19, and a pair of holding portions 18.
  • the frame 17 is attachable to the head 52 of the subject 5 and is attached to the head 52 in a first direction from the central portion (vertex) of the subject 5 to the left and right tragus It has a shape extending to D1.
  • the “center-center portion” is a position represented by an electrode symbol “Cz” in the international 10-20 method, and in the head 52 of the subject 5, the nose of the subject 5 and the occipital nodule And the line connecting the front end point of the left ear 521 and the front end point of the right ear 522 are crossing points.
  • the central central portion of the subject 5, the left tragus and the right tragus are connected along the head 52 in a state in which the frame 17 is attached to the head 52. It is a direction parallel to the curve.
  • the attachment portion 19 is provided on the frame 17 and can accommodate the electrode portion 11 used to collect brain waves of the subject 5.
  • the electrode unit 11 contacts a position corresponding to the measurement point 51 on the surface of the head 52 in a state where the frame 17 is attached to the head 52.
  • the frame 17 is provided with a pair of attachment portions 19.
  • the pair of holding portions 18 is connected to both ends of the frame 17 in the first direction D1, and contacts the head 52 in a state where the frame 17 is mounted on the head 52.
  • the holding portions 18 are provided at both ends of the frame 17 in the first direction D1.
  • maintenance parts 18 hold
  • the above-described electroencephalogram measurement system 10 is used, for example, in a rehabilitation support system 100 shown in FIG.
  • the rehabilitation support system 100 is a system for supporting the rehabilitation of the subject 5 using the electroencephalogram measurement system 10 including the headset 1.
  • the rehabilitation support system 100 supports rehabilitation by means of exercise therapy, with a person who has exercise paralysis or a decline in motor function or the like in a part of the body as a subject 5, for example, by a brain disease such as a stroke or an accident.
  • a voluntary exercise which is a movement performed by the subject 5 based on the intention or intention of the subject 5 may not be satisfied due to the inability or the deterioration of its function.
  • the “exercise therapy” referred to in the present disclosure is a disorder caused by exercising the inability part of such a voluntary exercise or a part where a decrease in function has occurred (hereinafter referred to as “disability site”) in the body of the subject 5 It means a method to restore the function of voluntary movement for the part.
  • the rehabilitation support system 100 includes an electroencephalogram measurement system 10 (including a headset 1), an exercise assistance device 3, and a control device 4.
  • the exercise assisting device 3 is a device that assists the exercise of the subject 5 by adding at least one of a mechanical stimulation and an electrical stimulation to the subject 5. Since the rehabilitation support system 100 is used for rehabilitation of the left finger of the subject 5, the exercise assisting apparatus 3 is mounted on the left hand of the subject 5 as shown in FIG. 1.
  • the rehabilitation support system 100 described below is used for the rehabilitation of the grasping motion and the extension motion by the left finger of the subject 5.
  • the “gripping operation” in the present disclosure means an operation of holding an object.
  • the “extension operation” in the present disclosure is grasped by an operation of opening the hand by the extension of four fingers 53 (second to fifth fingers) other than the first finger (thumb), that is, by the holding operation. It means the action of releasing the "object" of the state. That is, in the subject 5, the left finger is the injury site, and the rehabilitation support system 100 is used for the rehabilitation of the voluntary movement of the grasping motion and the extension motion by the left finger.
  • the rehabilitation support system 100 indirectly assists in the rehabilitation of the grasping motion by assisting the extension motion of the finger of the subject 5, instead of directly assisting the grasping motion of the subject 5. Do.
  • the rehabilitation support system 100 when the subject 5 tries to perform the extension motion as a voluntary exercise, the exercise assisting device 3 attached to the left hand of the subject 5 mechanically contacts the left finger 53 of the subject 5 And / or electrical stimulation to assist voluntary exercise. That is, the rehabilitation support system 100 assists the voluntary movement (extension movement) when releasing the peg 101 by the extension movement of the finger 53 from the posture in which the subject 5 holds the peg 101 (see FIG. 1) with the left finger. .
  • the present invention is not limited to this example, and the rehabilitation support system 100 may be used, for example, for rehabilitation of the right finger of the subject 5.
  • the exercise assistance device 3 has a finger drive device 31 and an electrical stimulation generator 32 as shown in FIG.
  • the finger driving device 31 holds four fingers 53 (second to fifth fingers) except the first finger (thumb) and applies mechanical stimulation (external force) to the four fingers 53. , Is a device to move the four fingers 53.
  • the finger driving device 31 includes, for example, a power source such as a motor or a solenoid, and moves the four fingers 53 by transmitting the force generated by the power source to the four fingers 53.
  • the finger drive device 31 moves the held four fingers 53 in a direction away from the first finger (i.e., extending movement) and moves the finger 53 in a direction approaching the first finger (i.e., gripping movement).
  • Two types of operations are possible: a closing operation.
  • the opening operation of the finger driving device 31 assists the extension operation of the subject 5
  • the closing operation of the finger driving device 31 assists the gripping operation of the subject 5.
  • the electrical stimulation generator 32 is a device that applies an electrical stimulation to a site for moving the finger 53 of the subject 5.
  • the site for moving the finger 53 of the subject 5 includes a site corresponding to at least one of the muscle and the nerve of the finger 53 of the subject 5.
  • the part for moving the finger 53 of the subject 5 is a part of the arm of the subject 5.
  • the electrical stimulation generator 32 includes, for example, a pad attached to the body (for example, an arm) of the subject 5.
  • the electrical stimulation generator 32 stimulates a site for moving the finger 53 by applying electrical stimulation (electric current) to the body of the subject 5 from the pad.
  • the control device 4 controls the exercise assistance device 3 based on the electroencephalogram information acquired by the electroencephalogram measurement system 10. In other words, the control device 4 controls the exercise assistance device 3 in accordance with the brain waves of the subject 5 collected by the electrode unit 11 of the headset 1.
  • the control device 4 is electrically connected to the information processing device 2 of the electroencephalogram measurement system 10 and the exercise assisting device 3.
  • the control device 4 is connected to a power cable for supplying operation power for the exercise assisting device 3 and the control device 4.
  • the control device 4 includes a drive circuit for driving the finger drive device 31 of the exercise assisting device 3 and an oscillation circuit for driving the electrical stimulation generator 32.
  • the control device 4 receives a control signal from the information processing device 2 by, for example, wired communication.
  • the drive circuit drives the finger drive device 31 of the exercise assisting device 3 and the finger drive device 31 performs an “open operation”. Control the exercise assisting device 3; Further, when the control device 4 receives the second control signal from the information processing device 2, the drive circuit drives the finger drive device 31 of the exercise assisting device 3 and the finger drive device 31 performs the “closing operation”. Control the exercise assistance device 3 to be controlled. In addition, when the control device 4 receives the third control signal from the information processing device 2, the control device 4 drives the electric stimulation generator 32 of the exercise assisting device 3 by the oscillation circuit, and the body of the subject 5 is electrically stimulated. The exercise assist device 3 is controlled to be given.
  • control device 4 controls the exercise assistance device 3 based on the control signal output from the electroencephalogram measurement system 10 to thereby provide the exercise assistance device based on the electroencephalogram information acquired by the electroencephalogram measurement system 10. It is possible to control three.
  • control device 4 controls the exercise assisting device 3 so that the “opening operation” and the “closing operation” are performed by the finger drive device 31 according to the operation of the operation switch provided in the control device 4 You can also.
  • the rehabilitation support system 100 assists the voluntary exercise It will be possible. Therefore, according to the rehabilitation support system 100, as in the case where the medical staff assists, rehabilitation by exercise therapy can be realized more effectively than when the subject 5 performs voluntary exercise alone.
  • the rehabilitation support system 100 can support the voluntary exercise of the subject 5 with the exercise assisting device 3 when the subject 5 tries to do voluntary exercise.
  • the rehabilitation support system 100 is an exercise assisting device 3 adapted to the voluntary exercise of the subject 5 by linking the exercise assisting device 3 to the brain wave (brain wave information) of the subject 5 measured by the electroencephalogram measurement system 10.
  • the rehabilitation support system 100 uses a brain-machine interface (BMI) technology to operate a machine (exercise assistance device 3) using brain activity (brain waves) to exercise Realize rehabilitation by therapy.
  • BMI brain-machine interface
  • characteristic changes in the electroencephalogram may occur. That is, when the subject 5 intends to perform voluntary exercise, activation of a brain region corresponding to a site targeted for voluntary exercise may occur.
  • An example of such a brain region is the somatosensory motor cortex.
  • a more effective rehabilitation can be expected if the exercise assist device 3 assists the voluntary exercise of the subject 5 according to the timing at which such activation of the brain region occurs.
  • Such activation of the brain region can be detected as a characteristic change of the electroencephalogram. Therefore, the rehabilitation support system 100 executes the assistance of the voluntary exercise of the subject 5 with the exercise assistance device 3 in accordance with the timing at which this characteristic change occurs.
  • Such characteristic changes may occur when the subject 5 images a voluntary exercise (that is, during an exercise attempt) even if the voluntary exercise is not actually performed. That is, such characteristic changes of the electroencephalogram can be activated if the corresponding brain region is activated by the intention of the subject 5 to perform the voluntary exercise, even though the voluntary movement is not actually performed. It can occur. Therefore, even for the subject 5 in a state in which voluntary exercise is impossible, the rehabilitation support system 100 can support voluntary exercise.
  • the electroencephalogram measurement system 10 detects, as a characteristic change, an intensity change of a specific frequency band that occurs in an electroencephalogram due to occurrence of event-related desynchronization (ERD).
  • the “event-related desynchronization” in the present disclosure means a phenomenon in which the power of a specific frequency band decreases in an electroencephalogram measured in the vicinity of the motor area during voluntary exercise (including recall of voluntary exercise).
  • “at the time of voluntary exercise” means a process from the intention of the subject 5 to voluntary exercise (recollection) to the success or failure of the voluntary exercise.
  • the "event-related desynchronization” can occur at the time of this voluntary movement, triggered by the intention (recollection) of the voluntary movement.
  • Frequency bands in which the power decreases due to event-related desynchronization are mainly ⁇ waves (for example, a frequency band of 8 Hz to less than 13 Hz) and ⁇ waves (for example, a frequency band of 13 Hz to less than 30 Hz).
  • the rehabilitation support system 100 having such a configuration, it is possible to realize effective rehabilitation by exercise therapy in the target person 5 while reducing the burden on the medical staff. Moreover, according to the rehabilitation support system 100, for example, there is no variation in the timing of assisting voluntary exercise due to human factors such as the skill of the medical staff who assists the voluntary exercise of the subject 5, and the variation of the effect of rehabilitation Is reduced. In particular, in the rehabilitation support system 100, the voluntary movement of the subject 5 can be assisted at the timing at which the characteristic change in the electroencephalogram (that is, the timing at which the brain region was actually activated). As described above, in the rehabilitation support system 100, since training can be performed according to the timing of brain activity, contribution to learning and establishment of correct brain activity can be expected. In particular, it is difficult for the subject 5 and the medical staff alone to determine whether or not a characteristic change has occurred in the electroencephalogram. Therefore, by using the rehabilitation support system 100, effective rehabilitation that is difficult to realize only by the target person 5 or the medical staff is possible.
  • the headset 1 includes a main body 15, a frame 17, and an electrode portion 11, as shown in FIGS. 3A and 3B.
  • the main body 15 is in the form of a box, and includes the signal processing unit 12, the communication unit 13, and the battery 14 inside (see FIG. 2).
  • the headset 1 is battery-powered, and power for operation of the signal processing unit 12 and the communication unit 13 is supplied from the battery 14.
  • the electrode unit 11 is an electrode for collecting the brain wave (brain wave signal) of the subject 5 and is, for example, a silver-silver chloride electrode.
  • the electrode unit 11 may be silver, gold, platinum or the like.
  • the electrode unit 11 has a first electrode 111 and a second electrode 112. As shown in FIG. 3B, the measurement point 51 set on the surface of the head 52 of the subject 5 includes a first measurement point 511 and a second measurement point 512.
  • the first electrode 111 is an electrode corresponding to the first measurement point 511, and is disposed on the first measurement point 511.
  • the second electrode 112 is an electrode corresponding to the second measurement point 512, and is disposed on the second measurement point 512.
  • the first measurement point 511 and the second measurement point 512 are located on the line connecting the center of the center of the head 52 and the point at which the front part of the right ear 522 is located.
  • the measurement points 511 and the second measurement points 512 are arranged in order.
  • the electroencephalogram measurement system 10 measures an electroencephalogram collected from the vicinity of the motor area corresponding to the injury site that is the target of rehabilitation.
  • the motor area corresponding to the left finger is in the right brain of the subject 5, and the motor area corresponding to the right finger is in the left brain of the subject 5.
  • the electrode part 11 (the 1st electrode 111 and the 2nd electrode 112) made to contact the right side of the head 52 of the subject 5
  • the electroencephalogram that is generated is the measurement target in the electroencephalogram measurement system 10. That is, the electrode part 11 (the 1st electrode 111 and the 2nd electrode 112) is arrange
  • the electrode portion 11 (the first electrode 111 and the second electrode 112) is disposed at a position represented by the electrode symbol "C4" in the international 10-20 method.
  • the measurement site consisting of a part of the left surface of the head 52 of the subject 5, for example, the electrode symbol "C3" in the international 10-20 method
  • the electrode portion 11 (the first electrode 111 and the second electrode 112) is disposed at the position to be displayed.
  • the headset 1 further includes a reference electrode 113 and a ground electrode 114.
  • the reference electrode 113 is an electrode for measuring a reference potential of an electroencephalogram signal measured by each of the first electrode 111 and the second electrode 112.
  • the reference electrode 113 is disposed at a rear position of either the left ear 521 or the right ear 522 in the head 52. Specifically, the reference electrode 113 is disposed at the head 52 at a position behind the ear on which the first electrode 111 and the second electrode 112 are disposed. In the illustrated example, since the first electrode 111 and the second electrode 112 are disposed on the right surface of the head 52, the reference electrode 113 is disposed at the rear position of the right ear 522.
  • the ground electrode 114 is disposed at the rear of the left ear 521 or the right ear 522 of the head 52 where the reference electrode 113 is not disposed. Since the reference electrode 113 is disposed at the rear position of the right ear 522, the ground electrode 114 is disposed at the rear position of the left ear 521.
  • Each of the reference electrode 113 and the ground electrode 114 is electrically connected to the main body 15 of the headset 1 by the electric wire 16, and is attached to the surface (scalp) of the head 52.
  • the position where the reference electrode 113 and the ground electrode 114 are disposed may be the earlobe instead of the position behind the ear as described above.
  • the posterior position of the ear and the earlobe are places in the head that are less susceptible to biopotentials from brain activity. That is, it is preferable that the reference electrode 113 and the ground electrode 114 be disposed at a position on the head that is not easily influenced by bioelectric potential derived from brain activity.
  • the signal processing unit 12 is electrically connected to the electrode unit 11, and performs signal processing on an electroencephalogram signal (electric signal) input from the electrode unit 11 to generate electroencephalogram information.
  • the electroencephalogram signal includes a voltage signal which is a potential difference between the potential of the first electrode 111 and a potential of the reference electrode 113, and a voltage signal which is a potential difference between the potential of the second electrode 112 and a potential of the reference electrode 113.
  • the headset 1 measures the brain waves of the subject 5 by measuring the action potential of the brain of the subject 5 by the electrode unit 11, and generates the brain wave information representing the brain waves by the signal processing unit 12.
  • the signal processing unit 12 includes at least an amplifier for amplifying an electroencephalogram signal and an A / D converter for A / D conversion, and outputs an electroencephalogram signal in digital form after amplification as electroencephalogram information.
  • the communication unit 13 has a communication function with the information processing device 2.
  • the communication unit 13 transmits at least the electroencephalogram information generated by the signal processing unit 12 to the information processing device 2.
  • the communication unit 13 can communicate bi-directionally with the information processing apparatus 2.
  • the communication method of the communication unit 13 is, for example, wireless communication conforming to Bluetooth (registered trademark) or the like. From the communication unit 13, electroencephalogram information is transmitted to the information processing device 2 as needed.
  • the frame 17 is horseshoe-like (in other words, in the form of an Alice band). That is, the frame 17 has a shape extending in the first direction D1 from the center portion toward the left tragus and the right tragus in a state where the frame 17 is mounted on the head 52.
  • the frame 17 is configured of a strip-shaped metal plate long in the first direction, and a resin cover that covers at least a part of the metal plate.
  • the frame 17 is flexible. Therefore, by bending the frame 17, it is possible to widen the distance between both ends of the frame 17 in the first direction D1. Therefore, when attaching the frame 17 to the head 52, the head 52 is inserted between both ends of the frame 17 in the first direction D1 by appropriately bending the frame 17 according to the size of the head 52. Is possible.
  • a main body 15 is attached to a central portion of the frame 17 in the first direction D1.
  • the main body 15 is an opening for confirming whether the main body 15 is disposed at an appropriate position with respect to the central portion in the center.
  • the part 151 is provided.
  • the opening 151 penetrates the main body 15 in a direction intersecting (orthogonal to) both the first direction D1 and the second direction D2.
  • the main body 15 is disposed at a position where the central portion of the head 52 can be seen through the opening 151 of the main body 15. , The mounting position of the headset 1 can be adjusted.
  • Holding portions 18 are connected to both ends of the frame 17 in the first direction D1.
  • the holding portion 18 in the state where the frame 17 is attached to the head 52, the holding portion 18 is connected to one end on the left tragus side of the frame 17 and one end on the right tragus side.
  • the holding unit 18 is configured to be movable along the first direction D1 with respect to the frame 17. That is, the distance between the holding portion 18 and one end of the frame 17 in the first direction D1 is adjustable.
  • the holding portion 18 has a base portion 18A and a pad 18B as shown in FIG. 3B.
  • the base 18A and the pad 18B are both curved along the head 52 when the frame 17 is attached to the head 52.
  • the base 18A is in the form of a flat rectangular parallelepiped elongated in the second direction D2, and is connected to the frame 17.
  • One end of the base 18A in the second direction D2 (here, one end on the occipital node side of the head 52) has a dimension in the first direction D1 larger than that of the other portion of the base 18A.
  • the surface fastener is provided in the part which opposes the head 52 among the base 18A.
  • the pad 18B has a flat rectangular parallelepiped shape that is long in the second direction D2, and is attached to the base 18A.
  • the pad 18B is located between the base 18A and the head 52 and in contact with the head 52 with the frame 17 mounted on the head 52.
  • the pad 18B is made of, for example, a urethane resin, and has a hardness lower than that of the base 18A. Therefore, the pad 18B comes into contact with the head 52 when the frame 17 is attached to the head 52, so that the pad 18B sandwiched between the headset 1 and the head 52 is deformed, and the head from the headset 1 is Reduce the force on 52.
  • a surface fastener is attached to a part of the pad 18B facing the base 18A. And the pad 18B is attached to the base 18A by bonding the surface fastener of the pad 18B to the surface fastener of the base 18A. Thus, the pad 18B is removable from the base 18A.
  • the pair of hooking portions 184 are provided at both ends of the holding portion 18 in the second direction D2.
  • the hooking portion 184 is formed in a hook shape, and one end of the band is configured to be hooked.
  • the band has a long shape along the circumferential direction (second direction D2) of the head 52 and has elasticity.
  • the band is attached to the head 52 by hooking both ends thereof to hooks 184 on the forehead side and / or the occipital side of the pair of holding portions 18, respectively.
  • the headset 1 is firmly fixed by the head 52. For this reason, it can suppress that position shift of the headset 1 arises by the change of the attitude
  • the frame 17 is further provided with a pair of attachment portions 19.
  • the pair of attachment portions 19 are provided on both sides of the main body 15 in the first direction D1. At least one of the pair of attachment portions 19 has a first electrode 111 and a second electrode 112. In the present embodiment, the mounting portion 19 on the right ear 522 side of the subject 5 among the pair of mounting portions 19 has the first electrode 111 and the second electrode 112.
  • the mounting portion 19 has a base 190, a first case 191, a second case 192, and a handle 193.
  • the base 190 has a shape that sandwiches the frame 17 in the second direction D2.
  • the base 190 is configured to be movable in the first direction D1 along the frame 17. Therefore, by adjusting the position of the base 190 with respect to the frame 17 in the first direction D1, it is possible to adjust the position of the electrode portion 11 (the first electrode 111 and the second electrode 112) as a result.
  • the handle 193 is provided on the base 190.
  • the handle 193 is used to selectively switch between a state in which the base 190 is fixed relative to the frame 17 and a state in which the base 190 is movable relative to the frame 17. Specifically, by tightening the handle 193, the base 190 is fixed to the frame 17. By loosening the handle 193, the base 190 can be moved relative to the frame 17.
  • Each of the first case 191 and the second case 192 is a cylindrical body having an elliptical bottom.
  • the first case 191 has a first bottom (a bottom facing the head 52) attached to the base 190, and the first electrode 111 and the second electrode 112 are held therein.
  • Each of the first electrode 111 and the second electrode 112 has a first end (one end facing the head 52) protruding from the first case 191.
  • the first electrode 111 and the second electrode 112 are both configured to be movable relative to the first case 191 so that the amount of protrusion from the first case 191 can be changed.
  • a coil spring is accommodated in the first case 191.
  • the coil spring is disposed between the second ends of the first electrode 111 and the second electrode 112 and the second bottom of the first case 191 (the bottom opposite to the first bottom). One end of the coil spring is fixed to the bottom of the first case 191.
  • the second case 192 has an open first end (one end facing the head 52), and the outer shape when viewed in the normal direction of the surface (scalp) of the head 52 is larger than that of the first case 191 .
  • the second case 192 is combined with the first case 191 so as to store a part of the first case 191 inside through the opening.
  • the second case 192 is configured to be movable relative to the first case 191 between the first position and the second position in the direction in which the coil spring expands and contracts. In the first position, the amount of projection of the first case 191 from the second case 192 is the smallest, and in the second position, the amount of projection of the first case 191 from the second case 192 is the largest.
  • the first end of the shaft passing through the second bottom of the first case 191 is fixed to the inner bottom of the second end of the second case 192 (the end opposite to the first end).
  • the second end of the shaft is fixed to the first electrode 111 and the second electrode 112. Therefore, by moving the second case 192 between the first position and the second position with respect to the first case 191, the first electrode 111 and the second electrode 112 are moved along with the movement of the second case 192 and the shaft. Move too. That is, by moving the second case 192 with respect to the first case 191, it is possible to adjust the amount of projection of the first electrode 111 and the second electrode 112 from the first case 191.
  • the second case 192 is configured to be movable in the second direction D2 with respect to the first case 191 at the second position. Then, the first end of the second case 192 is hooked on the second bottom of the first case 191 by moving the second case 192 in the second direction D2 at the second position.
  • the first electrode 111 and the second electrode 112 move to the inside of the first case 191.
  • the coil spring is compressed. Then, when the pulling force of the second case 192 is released, the first electrode 111 and the second electrode 112 return to the original state by the elastic force of the coil spring.
  • each of the first electrode 111 and the second electrode 112 When the headset 1 is attached to the head 52 of the subject 5, each of the first electrode 111 and the second electrode 112 is pushed by the head 52 and maintained in the state of being moved to the inside of the first case 191. Ru. That is, each of the first electrode 111 and the second electrode 112 pushes the measurement point 51 of the head 52 by the elastic force of the compressed coil spring.
  • the first electrode 111 and the second electrode 112 be in close contact with the measurement location 51 of the head 52. Therefore, in the headset 1, the adhesion between the first electrode 111 and the second electrode 112 and the measurement point 51 is enhanced by pressing the first electrode 111 and the second electrode 112 against the measurement point 51 by the elastic force of the coil spring. ing.
  • erythema tends to occur at the measurement point 51 where the first electrode 111 and the second electrode 112 are pressed. Become. Then, when erythema occurs in the measurement point 51, it is necessary to determine (evaluate) whether the erythema is persistent erythema or temporary erythema. It is considered that persistent erythema is caused by leakage of red blood cells due to the rupture of blood vessels and is likely to be wrinkled over time. Acupuncture and moxibustion are irreversibly obstructive, and often appear as erythema at the early stage of development. On the other hand, temporary erythema is reactive hyperemia due to the dilation of microvessels in the deep dermis and is not wrinkles.
  • a finger pressing method as a method of easily identifying persistent erythema and temporary erythema.
  • the examiner presses the erythema portion with a finger for 3 seconds to determine whether the erythema portion changes whitish or not.
  • the erythema part becomes white, it can be determined that it is a reversible skin condition (reactive hyperemia) and not a wrinkle, and when it does not disappear white, it can be determined as a persistent erythema due to persistent erythema.
  • the measurement accuracy of the erythema value may be significantly reduced due to the influence of the hair. Therefore, in assessing the inflammation (erythema) occurring at the measurement site 51 of the subject 5, it is desirable to reduce the influence of the hair on the measurement value (erythema value) as much as possible without shaving the hair.
  • an inflammation evaluation system (hereinafter referred to as an evaluation system) 6 according to the present embodiment will be described. As shown in FIG. 4, the evaluation system 6 uses the measured values (erythema value and melanin value) measured by the measuring device 7 to evaluate the inflammation of the affected area.
  • the measuring instrument 7 used in the evaluation system 6 of the present embodiment includes a probe 70, an LED drive circuit 71, a light receiving circuit 72, a control circuit 73, and a transmission circuit 74.
  • the probe 70 has a cylindrical probe body 700 having a cavity inside.
  • a circular opening 7000 is provided at the bottom of the probe body 700.
  • a plurality of (for example, 16) LEDs 702 and light receiving units 703 are accommodated in the internal space of the probe main body 700.
  • the plurality of LEDs 702 include a plurality of types of LEDs whose emission light wavelengths are different from each other, for example, an LED that emits green light with a wavelength of 568 nm, an LED that emits red light with a wavelength of 660 nm, and an infrared light with a wavelength of 880 nm And an LED that emits light.
  • the plurality of LEDs 702 including these three types of LEDs are disposed on one surface (the lower surface in FIG. 4) of the light shielding plate 701 provided in the probe main body 700.
  • the light shielding plate 701 is formed in a disk shape having a circular through hole 7010 at the center.
  • the light shielding plate 701 is disposed in the probe main body 700 so that the through hole 7010 faces the opening 7000 of the probe main body 700.
  • the light receiving unit 703 is, for example, a photoelectric conversion element in which a photodiode chip is accommodated in a can with a glass lens.
  • the light receiving portion 703 is not limited to a photoelectric conversion element having a photodiode chip, and may be a photoelectric conversion element having a phototransistor or the like.
  • the light receiving unit 703 is accommodated in the probe main body 700 such that the optical axis intersects the center of the opening 7000 of the probe main body 700 through the center of the through hole 7010 of the light shielding plate 701.
  • the LED drive circuit 71 is configured to be able to supply a drive current to emit light for each of the LEDs 702 of the same type whose emitted light has the same wavelength among the plurality of LEDs 702.
  • the LED drive circuit 71 includes a constant current circuit and an analog switch.
  • the analog switch turns on and off the electrical connection between the LED 702 of the same type and the constant current circuit.
  • the constant current circuit supplies a constant current to the plurality of LEDs 702 electrically connected through the analog switch. Note that turning on / off of the analog switch is controlled by the control circuit 73.
  • the light receiving circuit 72 applies a constant voltage in the forward direction to the light receiving unit 703, and measures the magnitude of the forward current flowing through the light receiving unit 703. Further, the light receiving circuit 72 outputs, to the control circuit 73, a measurement signal having a voltage value corresponding to the magnitude of the forward current (the amount of light received by the light receiving unit 703).
  • the control circuit 73 is configured of, for example, a microcontroller.
  • the control circuit 73 controls the LED drive circuit 71 to turn on and off the analog switch, and causes the LED drive circuit 71 to drive the plurality of LEDs 702 that emit light of the same wavelength among the plurality of LEDs 702. And transmitting a control signal to instruct.
  • the control circuit 73 AD converts and takes in the measurement signal output from the light receiving circuit 72, obtains the light intensity for each wavelength from data (measurement data) of the digitized measurement signal, and incorporates the obtained light intensity. Store in memory.
  • control circuit 73 measures the erythema value (hemoglobin concentration) using the light intensity of the green light and the light intensity of the red light of the three types of light (green light, red light, infrared light),
  • the melanin value (melanin pigment concentration) is measured using the light intensity of light and the light intensity of infrared light.
  • the control circuit 73 can measure the erythema value and the melanin value at once in a measurement process of about 1 second per time. That is, in the present embodiment, the melanin level (melanin pigment concentration) corresponds to the intensity value.
  • the transmission circuit 74 has, for example, a general-purpose serial communication interface such as RS-232C.
  • the transmission circuit 74 transmits data of the measurement value including the erythema value and the melanin value measured by the control circuit 73 to the evaluation system 6 through the transmission line.
  • the transmission circuit 74 can also receive data such as a control command from the evaluation system 6 via a transmission line.
  • the transmission circuit 74 may have, for example, a serial communication interface other than RS-232C such as RS-485 and USB (Universal Serial Bus), or may have a parallel communication interface.
  • the measuring device 7 includes a skin melanin pigment / hemoglobin measuring device (Mourameter MX18 manufactured by Courage + Khazaka electronic GmbH). If this skin melanin pigment / hemoglobin measuring device is used as the measuring device 7, it is possible to measure the erythema value and the melanin value of the measurement point 51 of the subject 5 in a short time.
  • the measuring device 7 is not limited to the above-mentioned skin melanin pigment / hemoglobin measuring device.
  • the evaluation system 6 of the present embodiment includes an acquisition unit 60 and an evaluation unit 61 as shown in FIG.
  • the evaluation system 6 preferably further includes a storage unit 62 and a notification unit 63.
  • the acquisition unit 60 performs data transmission with the transmission circuit 74 of the measurement instrument 7 via the transmission line, thereby acquiring a measurement value from the measurement instrument 7. That is, the acquisition unit 60 has the same communication interface as the communication interface of the transmission circuit 74 of the measuring instrument 7.
  • the evaluation unit 61 selects a measurement value that satisfies a predetermined condition from among a plurality of measurement values acquired by the acquisition unit 60 as a measurement value of an evaluation candidate. Furthermore, the evaluation unit 61 evaluates inflammation (erythema) of the affected area (the measurement point 51 of the head 52 of the subject 5) based on the measurement values of one or more evaluation candidates.
  • the storage unit 62 is preferably configured by an electrically rewritable non-volatile semiconductor memory such as a flash memory.
  • the notification unit 63 preferably includes a liquid crystal display and a drive circuit that drives the liquid crystal display.
  • the notification unit 63 notifies the evaluator of the evaluation result by causing a liquid crystal display to display a message or a symbol representing the evaluation result of the evaluation unit 61.
  • the notification unit 63 may have an acoustic device such as a buzzer or a speaker, and may notify the evaluation result by a sound (such as a buzzer or a voice message).
  • the acquisition unit 60, the evaluation unit 61, and the storage unit 62 may be configured as semiconductor components in which a computer system is integrated in one semiconductor chip like a microcontroller.
  • the acquisition unit 60, the evaluation unit 61, and the storage unit 62 may be configured by independent electronic circuits.
  • the evaluation unit 61 has hardware including a microprocessor and software including a program executed by the microprocessor.
  • the evaluation of the inflammation by the evaluation system 6 of the present embodiment is performed on the measurement point 51 of the head 52 of the subject 5 who has performed the rehabilitation by the rehabilitation support system 100 described above.
  • the evaluation unit 61 of the evaluation system 6 initializes (the variable of) the number of measurements n to 1 (step S1 in the flowchart of FIG. 5).
  • the operator operating the evaluation system 6 brings the probe 70 of the measuring instrument 7 into contact with the measurement point 51 of the subject 5 to measure the erythema value and the melanin value.
  • the operator once separates the probe 70 from the measurement location 51 of the subject 5 every time one measurement operation is completed, then contact the measurement location 51 again to start the next measurement operation, and the erythema value And the melanin level is measured a predetermined number of times (7 times in this embodiment).
  • the melanin level measured by the measuring instrument 7 is a value obtained by combining the concentration of the melanin pigment deposited on the scalp at the measurement point 51 and the concentration of the melanin pigment contained in the hair. That is, when the color of the hair of the subject 5 is black, it is estimated that the higher the melanin value, the greater the amount of hair sandwiched between the probe 70 and the measurement point 51 of the head 52. However, when the color of the hair of subject 5 is white (white hair), it is estimated that the lower the melanin value, the greater the amount of hair sandwiched between the probe 70 and the measurement point 51 of the head 52 . In the following description, the color of the hair of the subject 5 is black.
  • the acquiring unit 60 of the evaluation system 6 acquires seven measurement values (erythema value and melanin value) measured by the measuring device 7 from the measuring device 7 (step S2 in the flowchart of FIG. 5).
  • the evaluation unit 61 causes the storage unit 62 to store seven measurement values F 1 (Xk, Yk) acquired by the acquisition unit 60.
  • Xk is the k-th erythema value of the 7 measurements performed in one measurement operation
  • Y k is the k-th melanin value of the 7 measurements performed in the 1 measurement operation.
  • the evaluation unit 61 When the evaluation unit 61 receives seven measurement values F 1 (Xk, Yk) from the acquisition unit 60, the evaluation unit 61 increments the number of measurements n (step S3 in the flowchart of FIG. 5). (Step S4 in the flowchart of FIG. 5). If the number of measurements n is less than five, the evaluation unit 61 starts the countdown timer (step S5 in the flowchart of FIG. 5), and waits until the countdown timer counts up a predetermined time (for example, 15 minutes) ( Step S6 of the flowchart of FIG.
  • the operator measures the erythema value and the melanin value of the measurement point 51 of the subject 5 seven times using the measuring device 7.
  • the acquisition unit 60 of the evaluation system 6 acquires seven measurement values measured by the measuring device 7 from the measuring device 7 (step S2 in the flowchart of FIG. 5).
  • the evaluation unit 61 causes the storage unit 62 to store seven measurement values F 2 (Xk, Yk) acquired by the acquisition unit 60.
  • the evaluation unit 61 When the evaluation unit 61 receives seven measurement values F 2 (Xk, Yk) from the acquisition unit 60, the evaluation unit 61 increments the number of measurements n (step S3 in the flowchart of FIG. 5). (Step S4 in the flowchart of FIG. 5). If the number of measurements n is less than five, the evaluation unit 61 starts the countdown timer (step S5 in the flowchart of FIG. 5), and waits until the countdown timer counts up a predetermined time (step in the flowchart of FIG. 5) S6).
  • steps S2 to S6 in the flowchart of FIG. 5 are repeated every 15 minutes until 60 minutes have elapsed from the start of the evaluation.
  • the evaluation unit 61 evaluates from among the seven measured values F i (Xk, Yk) for each time from the first time (immediately after the start of evaluation) to the fifth time (after approximately 60 minutes from the start of evaluation).
  • the candidate measurement values are selected (step S7 in the flowchart of FIG. 6). That is, since the color of the hair of the subject 5 is black, the larger the amount of hair sandwiched between the probe 70 of the measuring instrument 7 and the scalp of the measuring point 51, the more the measured value F i (Xk, Yk) The melanin value Yk becomes high.
  • the evaluation unit 61 removes the measured value F i (Xk, Yk) whose melanin value Yk is equal to or higher than the predetermined upper limit (first threshold value) Yth from the evaluation target (evaluation candidate). Inflammation can be assessed using measurements F i (Xk, Yk), which are estimated to have relatively minor effects. However, it is preferable that the upper limit value Yth be set to a higher value as the melanin level of the scalp of the measurement location 51 of the subject 5 is higher.
  • FIG. 7 is a diagram in which seven measurement values F i (Xk, Yk) of the i-th are plotted in a two-dimensional orthogonal coordinate system in which the erythema value is taken on the X axis and the melanin value is taken on the Y axis.
  • the evaluation unit 61 determines four measured values F i (X1, Y1), F i (X2, Y2), F i (having a melanin value Yk equal to or higher than an upper limit value Yth indicated by a broken line parallel to the X axis in FIG. 7).
  • Three measurement values F i (X 3, Y 3), F i (X 5, Y 5), F i (X 6, Y 6) excluding X 4, Y 4) and F i (X 7, Y 7) are selected as measurement values of evaluation candidates .
  • the evaluation unit 61 calculates the average value of the erythema values in the measurement values of the evaluation candidates selected each time (step S8 in the flowchart of FIG. 6). The evaluation unit 61 determines whether the average value of the erythema values at each time decreases with the passage of time from the evaluation start time (when the headset 1 is removed from the head 52) (see the flowchart of FIG. 6). Step S9). In FIG.
  • the horizontal axis represents the elapsed time (0 minutes, 15 minutes, 30 minutes, 45 minutes, 60 minutes) from the time the headset 1 was removed from the head 52, and the average value of erythema values was vertical axis
  • the line graph which represented the time change of the mean value (it abbreviates to an average value hereafter) of the erythema value of each time is shown.
  • the average value of the time before the elapsed time of 0 minutes is an average value measured before (in advance) the subject 5 performs rehabilitation by the rehabilitation support system 100.
  • the evaluation unit 61 determines that the average value of each time decreases with the lapse of time from the evaluation start time, next, the absolute value of the difference between the final value (after 60 minutes) and the prior average value The value is compared to a predetermined threshold (step S10 of the flowchart of FIG. 6). If the absolute value of the difference between the final average value and the previous average value is equal to or less than the threshold value, the evaluation unit 61 particularly issues a problem because the erythema at the measurement point 51 of the subject 5 is a temporary erythema. It is determined that there is no (evaluation result OK) (step S11 in the flowchart of FIG. 6).
  • the evaluation unit 61 determines that there is (evaluation result NG) (step S12 in the flowchart of FIG. 6).
  • the evaluation unit 61 also determines that the evaluation result is NG when it is determined that the average value of each time does not decrease with the lapse of time from the evaluation start time (steps S9 and S12 in the flowchart of FIG. 6).
  • the evaluation unit 61 notifies the notification unit 63 of the evaluation result (step S13 in the flowchart of FIG. 6).
  • the evaluation system 6 evaluates whether the inflammation (erythema) produced at the measurement site 51 of the subject 5 is temporary erythema or persistent erythema as described above, and notifies the evaluation result . If the evaluation result is NG, that is, if the erythema at the measurement point 51 is evaluated as persistent erythema, it is desirable to stop the rehabilitation for the subject 5 and treat the erythema occurring at the measurement point 51 of the subject 5 .
  • the operation of the evaluation system described above is merely an example.
  • the evaluation unit 61 (microprocessor) performs final evaluation on the erythema of the measurement point 51
  • the worker measures the measurement point 51 based on the temporal change of the erythema value notified from the evaluation unit 61.
  • Final evaluation may be performed on erythema of
  • the same function as that of the evaluation system 6 may be embodied in a non-temporary recording medium that records a program for causing a computer system to execute the evaluation method.
  • the evaluation unit 61 removes the measurement value whose melanin value is less than a predetermined lower limit (second threshold) from the evaluation candidates, thereby making the hair (white hair) Inflammation can be assessed using measurements that are estimated to be relatively insensitive.
  • the lower limit value is set to a lower value as the melanin level of the scalp of the measurement point 51 of the subject 5 is lower.
  • a brain activity measuring device mounted on the head 52 of the subject 5
  • a head set configured to measure an electroencephalogram with an electroencephalogram electrode (electrode unit 11) in contact with the head 52
  • the brain activity measuring device is not limited to the headset 1.
  • Examples of brain activity measuring devices other than the headset 1 include, for example, functional near infrared spectroscopy devices.
  • the functional near-infrared spectroscopy device includes a light-emitting device that emits near-infrared light, and a photoelectric conversion device that receives near-infrared light and converts the light into an electrical signal.
  • a functional near infrared spectroscopy device brings a light emitting device and a photoelectric conversion device into contact with the scalp, emits near infrared light of the light emitting device into the brain, and reflects near infrared light (reflected light) reflected on the brain surface of the cerebral cortex
  • the blood flow state (brain activity) of the brain surface of the cerebral cortex is measured by photoelectrically converting the That is, in the functional near infrared spectroscopy device, when the measurement location 51 of the head 52 is pushed by the light emitting device and the photoelectric conversion device, erythema may occur at the measurement location 51.
  • the inflammation evaluation system (6) according to the first aspect of the present disclosure evaluates the inflammation that occurs in the skin.
  • the evaluation system (6) according to the first aspect is a measurement value including an erythema value at the measurement point (51) of the skin measured by the measuring instrument (7) and an intensity value (melanin value) different from the color of erythema
  • the evaluation system (6) according to the first aspect includes an evaluation unit (61) that evaluates inflammation based on erythema values included in the plurality of measurement values acquired by the acquisition unit (60).
  • the evaluation unit (61) selects a measurement value in which the intensity value (melanin value) in each of the plurality of measurement values is within a predetermined range as the measurement value of the evaluation candidate.
  • An evaluation part (61) evaluates inflammation based on the erythema value contained in the measured value of an evaluation candidate.
  • the inflammation evaluation system (6) according to the first aspect estimates that the influence of body hair growing on the skin is small by excluding measurement values whose intensity value (melanin value) is not within a predetermined range from evaluation candidates. The inflammation is assessed based on the erythema value being As a result, the inflammation evaluation system (6) according to the first aspect can suppress the reduction in the accuracy of the evaluation.
  • the inflammation evaluation system (6) according to the second aspect of the present disclosure can be realized by a combination with the first aspect.
  • the evaluation unit (61) determines a threshold value of at least one of a first threshold value and a second threshold value lower than the first threshold value. It is preferable to compare with the value. It is preferable that the evaluation unit (61) select a measurement value having a strength value equal to or less than a first threshold among the plurality of measurement values or a measurement value having a strength value equal to or more than a second threshold as measurement values of evaluation candidates.
  • the evaluation system (6) according to the second aspect can suppress the deterioration of the evaluation accuracy in any of the case where the color of body hair is black and the case where the color of body hair is white.
  • the inflammation evaluation system (6) according to the third aspect of the present disclosure can be realized by the combination with the first or second aspect.
  • the acquisition unit (60) preferably acquires a plurality of measurement values measured by the measuring instrument (7) at predetermined time intervals. It is preferable that an evaluation part (61) selects the measurement value of an evaluation candidate from the several measurement value acquired for every predetermined time. It is preferable that the evaluation unit (61) evaluates the inflammation based on a temporal change of the erythema value in the measurement value of the evaluation candidate.
  • the evaluation unit (61) evaluates the inflammation based on the temporal change of the erythema value in the measurement value of the evaluation candidate, so that the erythema due to inflammation is temporary erythema. It can be evaluated whether it corresponds to any of erythema and persistent erythema.
  • the inflammation evaluation system (6) according to the fourth aspect of the present disclosure can be realized by combination with any one of the first to third aspects.
  • the evaluation system (6) according to the fourth aspect preferably includes a storage unit (62) that stores the erythema value included in at least the measurement value of the evaluation candidate. It is preferable that an evaluation part (61) evaluates inflammation based on the erythema value memorize
  • the evaluation system (6) evaluates the inflammation based on the erythema value stored in the storage unit (62) by the evaluation unit (61). Inflammation can be assessed.
  • the evaluation method according to the fifth aspect of the present disclosure is an evaluation method for evaluating inflammation generated in the skin.
  • the evaluation method according to the fifth aspect acquires a measurement value including an intensity value of a color different from the color of the erythema and the color of the erythema at the measurement point (51) of the skin measured by the measuring instrument (7).
  • the evaluation method according to the fifth aspect selects a measurement value in which the intensity value (melanin value) in each of the plurality of measurement values falls within a predetermined range as the measurement value of the evaluation candidate.
  • the evaluation method which concerns on a 5th aspect evaluates inflammation based on the erythema value contained in the measured value of an evaluation candidate.
  • the evaluation method which concerns on a 5th aspect can aim at suppression of the precision fall of evaluation.
  • the program according to the sixth aspect of the present disclosure causes the computer system (evaluation unit 61) to execute the evaluation method according to the fifth aspect.
  • the program concerning a 6th mode can aim at control of a fall of accuracy of evaluation.
  • a non-transitory recording medium is a non-transitory recording medium readable by a computer system in which a program for causing a computer system to execute the evaluation method according to the fifth aspect is recorded. is there.
  • the non-temporary recording medium according to the seventh aspect can suppress deterioration in the accuracy of evaluation.

Abstract

A problem to be addressed by the present disclosure is to mitigate decreases in evaluation precision. An evaluation system (6) comprises an acquisition part (60) for acquiring a measurement value measured by a measurement device (7) on a skin measurement site (51), the measurement value including an erythema value and an intensity value (melanin value) for a color different from that of the erythema. The evaluation system (6) according to a first aspect comprises an evaluation part (61) for evaluating an inflammation on the basis of the erythema value included in a plurality of measurement values acquired with the acquisition part (60). The evaluation part (61) selects, from among the plurality of measurement values, a measurement value having an intensity value (melanin value) within a prescribed range as an evaluation-candidate measurement value. The evaluation part (61) evaluates the inflammation on the basis of the erythema value included in the evaluation-candidate measurement value.

Description

炎症の評価システム、評価方法、プログラム、及び非一時的記録媒体Evaluation system of inflammation, evaluation method, program, and non-temporary recording medium
 本開示は、炎症の評価システム、評価方法、プログラム、及び非一時的記録媒体に関し、より詳細には、人の皮膚に生じた炎症の程度を評価する評価システム、評価方法、プログラム、及び非一時的記録媒体に関する。 The present disclosure relates to an inflammation evaluation system, an evaluation method, a program, and a non-temporary recording medium, and more specifically, an evaluation system, an evaluation method, a program, and a non-temporary for evaluating the degree of inflammation generated in human skin. Recording medium.
 人の皮膚に生じる炎症の1つに紅斑がある。紅斑とは、真皮の毛細血管拡張もしくは充血によってもたらされる表皮の赤み(発赤)を指す発疹名である。このような炎症(紅斑)の程度を評価する評価方法の一例が特許文献1に記載されている。 One of the inflammations that occur in human skin is erythema. Erythema is a rash name that refers to the redness (redness) of the epidermis caused by capillary dilation or hyperemia of the dermis. Patent Document 1 describes an example of an evaluation method for evaluating the degree of such inflammation (erythema).
 特許文献1記載の評価方法は、紅斑が生じている皮膚領域又は粘膜領域の光反射率を測定し、L*a*b*色空間に従って前記測定結果のL*値及びa*値を取得し、取得した値を式(L*max-L*)×a*に代入して紅斑値を算出している。さらに、特許文献1記載の評価方法では、算出した紅斑値に基づいて炎症の有無並びに炎症の程度を評価している。 The evaluation method described in Patent Document 1 measures the light reflectance of a skin area or a mucous membrane area in which erythema has occurred, and acquires L * value and a * value of the measurement result according to L * a * b * color space. The erythema value is calculated by substituting the obtained value into the equation (L * max−L *) × a *. Furthermore, in the evaluation method described in Patent Document 1, the presence or absence of inflammation and the degree of inflammation are evaluated based on the calculated erythema value.
 ところで、紅斑値を測定する際に測定用のデバイスを皮膚に接触させる必要があるが、表皮に存在する体毛が測定用のデバイスと表皮との間に介在し、体毛の影響によって紅斑値の測定誤差が増加する可能性がある。紅斑値の測定誤差が増加すると、炎症の評価の精度も低下してしまう。 By the way, when measuring the erythema value, it is necessary to bring the device for measurement into contact with the skin, but the hair present in the epidermis intervenes between the device for measurement and the epidermis, and the erythema value is measured by the influence of the body hair Errors can increase. As the measurement error of the erythema value increases, the accuracy of the evaluation of inflammation also decreases.
特表2016-518885号公報JP 2016-518885 gazette
 本開示の目的は、評価の精度低下の抑制を図ることができる炎症の評価システム、評価方法、プログラム、及び非一時的記録媒体を提供することである。 An object of the present disclosure is to provide an inflammation evaluation system, an evaluation method, a program, and a non-temporary recording medium capable of suppressing reduction in accuracy of evaluation.
 本開示の一態様に係る炎症の評価システムは、皮膚に生じる炎症を評価する評価システムである。前記評価システムは、測定器によって測定される前記皮膚の測定箇所における紅斑値及び紅斑の色と異なる色の強度値を含む測定値を取得する取得部と、前記取得部で取得する複数の前記測定値に含まれる前記紅斑値に基づいて炎症を評価する評価部とを備える。前記評価部は、複数の前記測定値の各々における前記紅斑値と前記強度値を比較し、比較した前記紅斑値と前記強度値の比率が所定の範囲内に収まっている測定値を評価候補の測定値に選出する。前記評価部は、前記評価候補の測定値に含まれる前記紅斑値に基づいて炎症を評価する。 An inflammation evaluation system according to an aspect of the present disclosure is an evaluation system that evaluates inflammation generated in the skin. The evaluation system acquires an acquisition unit that acquires a measurement value including an intensity value of a color different from the erythema value and the color of the erythema at the measurement site of the skin measured by a measuring instrument, and the plurality of measurements acquired by the acquisition unit And an evaluation unit that evaluates inflammation based on the erythema value included in the value. The evaluation unit compares the erythema value and the intensity value in each of the plurality of measurement values, and compares the erythema value and the intensity value in the comparison with each other, and the measurement value is within a predetermined range as an evaluation candidate Elect to be a measured value. The evaluation unit evaluates inflammation based on the erythema value included in the measurement value of the evaluation candidate.
 本開示の一態様に係る評価方法は、皮膚に生じる炎症を評価する評価方法である。前記評価方法では、測定器によって測定される前記皮膚の測定箇所における紅斑値及び紅斑の色と異なる色の強度値を含む測定値を取得し、複数の前記測定値の各々における前記紅斑値と前記強度値を比較する。前記評価方法では、比較した前記紅斑値と前記強度値の比率が所定の範囲内に収まっている測定値を評価候補の測定値に選出し、前記評価候補の測定値に含まれる前記紅斑値に基づいて炎症を評価する。 The evaluation method according to an aspect of the present disclosure is an evaluation method for evaluating inflammation generated in the skin. In the evaluation method, a measurement value including an intensity value of a color different from the color of the erythema and the color of the erythema at the measurement site of the skin measured by a measuring device is obtained, Compare intensity values. In the evaluation method, a measurement value in which the ratio of the erythema value and the intensity value compared is within a predetermined range is selected as the measurement value of the evaluation candidate, and the erythema value included in the measurement value of the evaluation candidate is selected. Assess inflammation based on:
 本開示の一態様に係るプログラムは、コンピュータシステムに、前記評価方法を実行させる。 A program according to an aspect of the present disclosure causes a computer system to execute the evaluation method.
 本開示の一態様に係る非一時的記録媒体は、コンピュータシステムに、脳活動計測装置の評価方法を実行させるためのプログラムを記録した、コンピュータシステムで読み取り可能な非一時的記録媒体である。 The non-temporary recording medium according to an aspect of the present disclosure is a computer system-readable non-temporary recording medium in which a program for causing a computer system to execute a method of evaluating a brain activity measuring device is recorded.
図1は、本開示の一実施形態に係る炎症の評価システムの評価対象である対象者の頭部に装着されるヘッドセットを含む脳波測定システム、及びそれを備えたリハビリテーション支援システムの使用状態を示す概略図である。FIG. 1 shows a state of use of an electroencephalogram measurement system including a headset mounted on the head of a subject who is a subject of evaluation of an inflammation evaluation system according to an embodiment of the present disclosure, and a rehabilitation support system including the same. FIG. 図2は、同上の脳波測定システム及びリハビリテーション支援システムの構成を示すブロック図である。FIG. 2 is a block diagram showing the configuration of the above-mentioned electroencephalogram measurement system and rehabilitation support system. 図3Aは、同上のヘッドセットの使用状態を示す概略上面図である。図3Bは、同上のヘッドセットの使用状態を示す概略正面図である。FIG. 3A is a schematic top view showing the usage state of the above headset. FIG. 3B is a schematic front view showing the usage state of the above headset. 図4は、同上の評価システムのシステム構成図である。FIG. 4 is a system configuration diagram of the above evaluation system. 図5は、同上の評価システムの動作を説明するためのフローチャートである。FIG. 5 is a flowchart for explaining the operation of the evaluation system of the same. 図6は、同上の評価システムの動作を説明するためのフローチャートである。FIG. 6 is a flowchart for explaining the operation of the evaluation system of the same. 図7は、同上の評価システムにおける測定値を説明するための説明図である。FIG. 7 is an explanatory diagram for explaining measurement values in the evaluation system of the same. 図8は、同上の評価システムの動作を説明するための折れ線グラフを示す図である。FIG. 8 is a diagram showing a line graph for explaining the operation of the evaluation system of the same.
 下記の実施形態において説明する各図は模式的な図であり、各構成要素の大きさ、厚さ、及びそれらの比が必ずしも実際の寸法比を反映しているとは限らない。なお、以下の実施形態で説明する構成は本開示の一例にすぎない。本開示は、以下の実施形態に限定されず、本開示の効果を奏することができれば、設計等に応じて種々の変更が可能である。 Each drawing described in the following embodiments is a schematic drawing, and the size, thickness, and ratio of each component do not necessarily reflect the actual dimensional ratio. The configuration described in the following embodiment is merely an example of the present disclosure. The present disclosure is not limited to the following embodiments, and various modifications can be made according to design etc. as long as the effects of the present disclosure can be obtained.
 本実施形態に係る評価システムを説明するにあたり、評価システムの評価対象となる炎症について説明する。評価対象となる炎症は、例えば、脳活動計測装置(以下、ヘッドセット1と呼ぶ。)を頭部に装着することによって生じる炎症である。ヘッドセット1は、図1に示すように、情報処理装置2とともに脳波測定システム10を構成している。 In describing the evaluation system according to the present embodiment, inflammation to be evaluated in the evaluation system will be described. The inflammation to be evaluated is, for example, inflammation caused by wearing a brain activity measuring apparatus (hereinafter referred to as a headset 1) on the head. The headset 1 constitutes an electroencephalogram measurement system 10 together with an information processing apparatus 2 as shown in FIG.
 脳波測定システム10は、対象者5の脳波を測定するためのシステムであって、対象者5の頭部52の一部である測定箇所51に対応する位置に配置される電極部11から、脳波情報を取得する。本開示でいう「脳波」(Electroencephalogram:EEG)とは、大脳の神経細胞(群)の発する電気信号(活動電位)を体外に導出し、記録した波形を意味する。本開示においては、特に断りが無い限り、大脳皮質の多数のニューロン群(神経網)の総括的な活動電位を対象として、これを頭皮に装着した電極部11を用いて記録する頭皮上脳波を「脳波」という。 The electroencephalogram measurement system 10 is a system for measuring the electroencephalogram of the subject 5, and the electroencephalogram from the electrode unit 11 disposed at a position corresponding to the measurement point 51 which is a part of the head 52 of the subject 5 Get information. The term “electroencephalogram (EEG)” as referred to in the present disclosure means a waveform obtained by extruding an electrical signal (action potential) emitted from a cerebral nerve cell (group) and recording it. In the present disclosure, unless otherwise noted, an on-scalp electroencephalogram recorded using the electrode unit 11 attached to the scalp with respect to general action potentials of a large number of neuron groups (neural networks) of the cerebral cortex. It is called "brain wave".
 脳波測定システム10は、電極部11を有するヘッドセット1(図3B参照)と、情報処理装置2と、を備えている。ヘッドセット1は、対象者5の頭部52の表面(頭皮)に電極部11を接触させた状態で、対象者5の頭部52に装着される。本開示では、電極部11は、頭部52の表面に塗布されたペースト(電極糊)上に載せられることで、頭部52の表面に接触する。このとき、電極部11は、毛髪をかき分けることにより、毛髪を介さずに頭部52の表面に接触する。もちろん、電極部11は、ペーストを塗布することなく、頭部52の表面に直接、接触してもよい。つまり、本開示では、「電極部11を頭部52の表面に接触させる」とは、電極部11を直接、頭部52の表面(頭皮を含む)に接触させることの他、中間物を介して電極部11を間接的に頭部52の表面に接触させることも含む。中間物は、ペーストに限定されず、例えば導電性を有するゲルであってもよい。 The electroencephalogram measurement system 10 includes a headset 1 (see FIG. 3B) having an electrode unit 11 and an information processing device 2. The headset 1 is mounted on the head 52 of the subject 5 with the electrode unit 11 in contact with the surface (scalp) of the head 52 of the subject 5. In the present disclosure, the electrode unit 11 contacts the surface of the head 52 by being placed on the paste (electrode paste) applied to the surface of the head 52. At this time, the electrode unit 11 contacts the surface of the head 52 without the hair by scraping the hair. Of course, the electrode unit 11 may be in direct contact with the surface of the head 52 without applying a paste. That is, in the present disclosure, “contacting the electrode unit 11 with the surface of the head 52” refers to contacting the electrode unit 11 directly with the surface of the head 52 (including the scalp) or via an intermediate. It also includes bringing the electrode portion 11 into contact with the surface of the head 52 indirectly. The intermediate is not limited to the paste, and may be, for example, a gel having conductivity.
 ヘッドセット1は、電極部11にて対象者5の脳の活動電位を測定することで対象者5の脳波を測定し、脳波を表す脳波情報を生成する。ヘッドセット1は、例えば、無線通信により、脳波情報を情報処理装置2に送信する。 The headset 1 measures the brain waves of the subject 5 by measuring the action potential of the brain of the subject 5 with the electrode unit 11, and generates brain wave information representing the brain waves. The headset 1 transmits brain wave information to the information processing apparatus 2 by wireless communication, for example.
 情報処理装置2は、例えば、パーソナルコンピュータ等のコンピュータシステムを主構成とする。情報処理装置2は、例えば、無線通信により、ヘッドセット1からの脳波情報を受信し、ヘッドセット1から取得した脳波情報に対して、種々の処理を施したり、脳波情報を表示したりする。本実施形態では、対象者5が随意運動(voluntary movement)を行う際に生じる(つまり、対象者5が随意運動を行おうと企図した際に生じ得る)特徴的な変化を含む脳波の検出、及びキャリブレーション(calibration)処理等は、情報処理装置2にて行われる。本開示でいう「キャリブレーション処理」は、脳波情報の解析、つまり検出対象となる脳波の検出に用いる各種のパラメータを決定するための処理である。 The information processing apparatus 2 mainly includes, for example, a computer system such as a personal computer. The information processing apparatus 2 receives brain wave information from the headset 1 by wireless communication, for example, performs various processes on the brain wave information acquired from the headset 1, and displays the brain wave information. In the present embodiment, detection of an electroencephalogram including characteristic changes that occur when the subject 5 performs a voluntary movement (that is, can occur when the subject 5 intends to perform a voluntary exercise), and The calibration process and the like are performed by the information processing apparatus 2. The “calibration process” in the present disclosure is a process for analyzing brain wave information, that is, for determining various parameters used for detection of a brain wave to be detected.
 次に、ヘッドセット1について、図1、図3A及び図3Bを用いて説明する。なお、図面に示す「D1」及び「D2」の矢印は、いずれも説明のために表記しているに過ぎず、実体を伴わない。 Next, the headset 1 will be described with reference to FIGS. 1, 3A and 3B. Note that the arrows of “D1” and “D2” shown in the drawings are only shown for the sake of explanation, and do not have an entity.
 ヘッドセット1は、フレーム17と、取付部19と、一対の保持部18と、を備えている。フレーム17は、対象者5の頭部52に装着可能であって、頭部52に装着された状態で対象者5の正中中心部(vertex)から左耳珠及び右耳珠に向かう第1方向D1に延びた形状を有している。本開示でいう「正中中心部」は、国際10-20法において電極記号「Cz」で表される位置であって、対象者5の頭部52において、対象者5の鼻根と後頭結節とを結ぶ線と、左耳521の耳珠前点と右耳522の耳珠前点とを結ぶ線が交差する部位である。また、本開示でいう「第1方向」は、フレーム17が頭部52に装着された状態において、対象者5の正中中心部、左耳珠、及び右耳珠を頭部52に沿って結ぶ曲線と平行な方向である。 The headset 1 includes a frame 17, an attachment portion 19, and a pair of holding portions 18. The frame 17 is attachable to the head 52 of the subject 5 and is attached to the head 52 in a first direction from the central portion (vertex) of the subject 5 to the left and right tragus It has a shape extending to D1. In the present disclosure, the “center-center portion” is a position represented by an electrode symbol “Cz” in the international 10-20 method, and in the head 52 of the subject 5, the nose of the subject 5 and the occipital nodule And the line connecting the front end point of the left ear 521 and the front end point of the right ear 522 are crossing points. Further, in the “first direction” in the present disclosure, the central central portion of the subject 5, the left tragus and the right tragus are connected along the head 52 in a state in which the frame 17 is attached to the head 52. It is a direction parallel to the curve.
 取付部19は、フレーム17に設けられて、対象者5の脳波を採取するために用いられる電極部11を収納可能である。電極部11は、フレーム17が頭部52に装着された状態で、頭部52の表面の測定箇所51に対応する位置に接触する。フレーム17には、一対の取付部19が設けられている。 The attachment portion 19 is provided on the frame 17 and can accommodate the electrode portion 11 used to collect brain waves of the subject 5. The electrode unit 11 contacts a position corresponding to the measurement point 51 on the surface of the head 52 in a state where the frame 17 is attached to the head 52. The frame 17 is provided with a pair of attachment portions 19.
 一対の保持部18は、フレーム17の第1方向D1の両端に繋がっており、フレーム17が頭部52に装着された状態で頭部52に接触する。言い換えれば、フレーム17の第1方向D1の両端には、それぞれ保持部18が設けられている。そして、これら保持部18は、フレーム17が頭部52に装着された状態で頭部52に接触することにより、頭部52に対してフレーム17を保持する。 The pair of holding portions 18 is connected to both ends of the frame 17 in the first direction D1, and contacts the head 52 in a state where the frame 17 is mounted on the head 52. In other words, the holding portions 18 are provided at both ends of the frame 17 in the first direction D1. And these holding | maintenance parts 18 hold | maintain the flame | frame 17 with respect to the head 52 by contacting the head 52 in the state with which the flame | frame 17 was mounted | worn with the head 52. As shown in FIG.
 上述した脳波測定システム10は、例えば、図1に示すリハビリテーション支援システム100に用いられる。 The above-described electroencephalogram measurement system 10 is used, for example, in a rehabilitation support system 100 shown in FIG.
 リハビリテーション支援システム100は、ヘッドセット1を含む脳波測定システム10を用いて、対象者5のリハビリテーションを支援するためのシステムである。リハビリテーション支援システム100は、例えば、脳卒中等の脳疾患又は事故等によって、身体の一部に運動麻痺又は運動機能の低下等が生じた人を対象者5として、運動療法によるリハビリテーションを支援する。このような対象者5においては、対象者5が自己の意思又は意図に基づいて行う運動である随意運動が、不能又はその機能の低下により満足にできないことがある。本開示でいう「運動療法」は、対象者5の身体のうち、このような随意運動の不能部位又は機能の低下が生じた部位(以下、「障害部位」という)を運動させることにより、障害部位について随意運動の機能の回復を図る方法を意味する。 The rehabilitation support system 100 is a system for supporting the rehabilitation of the subject 5 using the electroencephalogram measurement system 10 including the headset 1. The rehabilitation support system 100 supports rehabilitation by means of exercise therapy, with a person who has exercise paralysis or a decline in motor function or the like in a part of the body as a subject 5, for example, by a brain disease such as a stroke or an accident. In such a subject 5, a voluntary exercise which is a movement performed by the subject 5 based on the intention or intention of the subject 5 may not be satisfied due to the inability or the deterioration of its function. The “exercise therapy” referred to in the present disclosure is a disorder caused by exercising the inability part of such a voluntary exercise or a part where a decrease in function has occurred (hereinafter referred to as “disability site”) in the body of the subject 5 It means a method to restore the function of voluntary movement for the part.
 リハビリテーション支援システム100は、図1及び図2に示すように、脳波測定システム10(ヘッドセット1を含む)と、運動補助装置3と、制御装置4と、を備えている。 As shown in FIGS. 1 and 2, the rehabilitation support system 100 includes an electroencephalogram measurement system 10 (including a headset 1), an exercise assistance device 3, and a control device 4.
 運動補助装置3は、対象者5に機械的な刺激と電気的な刺激との少なくとも一方を加えて、対象者5の運動を補助する装置である。運動補助装置3は、対象者5の左手指のリハビリテーションにリハビリテーション支援システム100が用いられるので、図1に示すように、対象者5の左手に装着される。 The exercise assisting device 3 is a device that assists the exercise of the subject 5 by adding at least one of a mechanical stimulation and an electrical stimulation to the subject 5. Since the rehabilitation support system 100 is used for rehabilitation of the left finger of the subject 5, the exercise assisting apparatus 3 is mounted on the left hand of the subject 5 as shown in FIG. 1.
 以下に説明するリハビリテーション支援システム100は、対象者5の左手指による把持動作及び伸展動作のリハビリテーションに用いられる。本開示でいう「把持動作」は、物をつかむ動作のことを意味する。また、本開示でいう「伸展動作」は、第1指(親指)を除く4本の手指53(第2指~第5指)の伸展により、手を開く動作、つまり把持動作によりつかんでいる状態の「物」を放す動作のことを意味する。つまり、この対象者5においては左手指が障害部位であって、リハビリテーション支援システム100は、左手指による把持動作及び伸展動作という随意運動についてのリハビリテーションに用いられる。ただし、実際には、リハビリテーション支援システム100は、対象者5の把持動作を直接的に補助するのではなく、対象者5の手指の伸展動作を補助することで、間接的に把持動作のリハビリテーションを行う。 The rehabilitation support system 100 described below is used for the rehabilitation of the grasping motion and the extension motion by the left finger of the subject 5. The “gripping operation” in the present disclosure means an operation of holding an object. In addition, the “extension operation” in the present disclosure is grasped by an operation of opening the hand by the extension of four fingers 53 (second to fifth fingers) other than the first finger (thumb), that is, by the holding operation. It means the action of releasing the "object" of the state. That is, in the subject 5, the left finger is the injury site, and the rehabilitation support system 100 is used for the rehabilitation of the voluntary movement of the grasping motion and the extension motion by the left finger. However, in reality, the rehabilitation support system 100 indirectly assists in the rehabilitation of the grasping motion by assisting the extension motion of the finger of the subject 5, instead of directly assisting the grasping motion of the subject 5. Do.
 そのため、リハビリテーション支援システム100では、対象者5が随意運動として伸展動作を行おうとする場合に、対象者5の左手に装着された運動補助装置3が、対象者5の左の手指53に機械的な刺激と電気的な刺激との少なくとも一方を加えて、随意運動を補助する。すなわち、リハビリテーション支援システム100は、対象者5が、ペグ101(図1参照)を左手指でつかんだ姿勢から、手指53の伸展動作によりペグ101を放す際の随意運動(伸展動作)を補助する。ただし、この例に限らず、リハビリテーション支援システム100は、例えば、対象者5の右手指のリハビリテーションに用いられてもよい。 Therefore, in the rehabilitation support system 100, when the subject 5 tries to perform the extension motion as a voluntary exercise, the exercise assisting device 3 attached to the left hand of the subject 5 mechanically contacts the left finger 53 of the subject 5 And / or electrical stimulation to assist voluntary exercise. That is, the rehabilitation support system 100 assists the voluntary movement (extension movement) when releasing the peg 101 by the extension movement of the finger 53 from the posture in which the subject 5 holds the peg 101 (see FIG. 1) with the left finger. . However, the present invention is not limited to this example, and the rehabilitation support system 100 may be used, for example, for rehabilitation of the right finger of the subject 5.
 運動補助装置3は、図2に示すように、手指駆動装置31と、電気刺激発生装置32と、を有している。 The exercise assistance device 3 has a finger drive device 31 and an electrical stimulation generator 32 as shown in FIG.
 手指駆動装置31は、第1指(親指)を除く4本の手指53(第2指~第5指)を保持し、これら4本の手指53に機械的な刺激(外力)を与えることによって、4本の手指53を動かす装置である。手指駆動装置31は、例えば、モータ又はソレノイド等の動力源を含み、動力源で発生した力を4本の手指53に伝えることによって、4本の手指53を動かす。手指駆動装置31では、保持した4本の手指53を、第1指から離れる向きに移動(つまり伸展運動)させる「開動作」と、第1指に近づく向きに移動(つまり把持運動)させる「閉動作」と、の2種類の動作が可能である。手指駆動装置31の開動作により対象者5の伸展動作が補助され、手指駆動装置31の閉動作により対象者5の把持動作が補助される。 The finger driving device 31 holds four fingers 53 (second to fifth fingers) except the first finger (thumb) and applies mechanical stimulation (external force) to the four fingers 53. , Is a device to move the four fingers 53. The finger driving device 31 includes, for example, a power source such as a motor or a solenoid, and moves the four fingers 53 by transmitting the force generated by the power source to the four fingers 53. The finger drive device 31 moves the held four fingers 53 in a direction away from the first finger (i.e., extending movement) and moves the finger 53 in a direction approaching the first finger (i.e., gripping movement). Two types of operations are possible: a closing operation. The opening operation of the finger driving device 31 assists the extension operation of the subject 5, and the closing operation of the finger driving device 31 assists the gripping operation of the subject 5.
 電気刺激発生装置32は、対象者5の手指53を動かすための部位に、電気的な刺激を与える装置である。ここで、対象者5の手指53を動かすための部位は、対象者5の手指53の筋肉と神経との少なくとも一方に対応する部位を含む。例えば、対象者5の手指53を動かすための部位は、対象者5の腕の一部である。電気刺激発生装置32は、例えば、対象者5の身体(例えば腕)に貼り付けられるパッドを含む。、電気刺激発生装置32は、パッドから対象者5の身体に電気的な刺激(電流)を与えることによって、手指53を動かすための部位へ刺激を与える。 The electrical stimulation generator 32 is a device that applies an electrical stimulation to a site for moving the finger 53 of the subject 5. Here, the site for moving the finger 53 of the subject 5 includes a site corresponding to at least one of the muscle and the nerve of the finger 53 of the subject 5. For example, the part for moving the finger 53 of the subject 5 is a part of the arm of the subject 5. The electrical stimulation generator 32 includes, for example, a pad attached to the body (for example, an arm) of the subject 5. The electrical stimulation generator 32 stimulates a site for moving the finger 53 by applying electrical stimulation (electric current) to the body of the subject 5 from the pad.
 制御装置4は、脳波測定システム10にて取得された脳波情報に基づいて、運動補助装置3を制御する。言い換えれば、制御装置4は、ヘッドセット1の電極部11にて採取された対象者5の脳波に応じて、運動補助装置3を制御する。制御装置4は、脳波測定システム10の情報処理装置2、及び運動補助装置3に対して電気的に接続されている。制御装置4には、運動補助装置3及び制御装置4の動作用電力を供給するための電源ケーブルが接続されている。制御装置4は、運動補助装置3の手指駆動装置31を駆動するための駆動回路、及び電気刺激発生装置32を駆動するための発振回路を含んでいる。制御装置4は、例えば、有線通信により、情報処理装置2から制御信号を受信する。 The control device 4 controls the exercise assistance device 3 based on the electroencephalogram information acquired by the electroencephalogram measurement system 10. In other words, the control device 4 controls the exercise assistance device 3 in accordance with the brain waves of the subject 5 collected by the electrode unit 11 of the headset 1. The control device 4 is electrically connected to the information processing device 2 of the electroencephalogram measurement system 10 and the exercise assisting device 3. The control device 4 is connected to a power cable for supplying operation power for the exercise assisting device 3 and the control device 4. The control device 4 includes a drive circuit for driving the finger drive device 31 of the exercise assisting device 3 and an oscillation circuit for driving the electrical stimulation generator 32. The control device 4 receives a control signal from the information processing device 2 by, for example, wired communication.
 制御装置4は、情報処理装置2から第1の制御信号を受信すると、駆動回路にて運動補助装置3の手指駆動装置31を駆動し、手指駆動装置31にて「開動作」が行われるように運動補助装置3を制御する。また、制御装置4は、情報処理装置2から第2の制御信号を受信すると、駆動回路にて運動補助装置3の手指駆動装置31を駆動し、手指駆動装置31にて「閉動作」が行われるように運動補助装置3を制御する。また、制御装置4は、情報処理装置2から第3の制御信号を受信すると、発振回路にて運動補助装置3の電気刺激発生装置32を駆動し、対象者5の身体に電気的な刺激が与えられるように運動補助装置3を制御する。 When the control device 4 receives the first control signal from the information processing device 2, the drive circuit drives the finger drive device 31 of the exercise assisting device 3 and the finger drive device 31 performs an “open operation”. Control the exercise assisting device 3; Further, when the control device 4 receives the second control signal from the information processing device 2, the drive circuit drives the finger drive device 31 of the exercise assisting device 3 and the finger drive device 31 performs the “closing operation”. Control the exercise assistance device 3 to be controlled. In addition, when the control device 4 receives the third control signal from the information processing device 2, the control device 4 drives the electric stimulation generator 32 of the exercise assisting device 3 by the oscillation circuit, and the body of the subject 5 is electrically stimulated. The exercise assist device 3 is controlled to be given.
 このように、制御装置4は、脳波測定システム10から出力される制御信号に基づいて、運動補助装置3を制御することによって、脳波測定システム10にて取得された脳波情報に基づいて運動補助装置3を制御することが可能である。また、制御装置4は、制御装置4に備えられた操作スイッチの操作に応じて、手指駆動装置31にて「開動作」及び「閉動作」が行われるように運動補助装置3を制御することもできる。 As described above, the control device 4 controls the exercise assistance device 3 based on the control signal output from the electroencephalogram measurement system 10 to thereby provide the exercise assistance device based on the electroencephalogram information acquired by the electroencephalogram measurement system 10. It is possible to control three. In addition, the control device 4 controls the exercise assisting device 3 so that the “opening operation” and the “closing operation” are performed by the finger drive device 31 according to the operation of the operation switch provided in the control device 4 You can also.
 例えば、理学療法士又は作業療法士等の医療スタッフが、対象者5の手指53を持って対象者5の随意運動を補助する場合と同様に、リハビリテーション支援システム100にて、随意運動の補助が可能になる。そのため、リハビリテーション支援システム100によれば、医療スタッフが補助する場合と同様に、対象者5が単独で随意運動を行う場合に比べて効果的な、運動療法によるリハビリテーションを実現可能となる。 For example, as in the case where a medical staff such as a physical therapist or an occupational therapist holds the finger 53 of the subject 5 to assist the voluntary exercise of the subject 5, the rehabilitation support system 100 assists the voluntary exercise It will be possible. Therefore, according to the rehabilitation support system 100, as in the case where the medical staff assists, rehabilitation by exercise therapy can be realized more effectively than when the subject 5 performs voluntary exercise alone.
 ところで、上述のようなリハビリテーションを支援するためには、リハビリテーション支援システム100は、対象者5が随意運動を行おうとする場合に、運動補助装置3にて対象者5の随意運動を補助することが望ましい。リハビリテーション支援システム100は、脳波測定システム10にて測定された対象者5の脳波(脳波情報)に、運動補助装置3を連動させることにより、対象者5の随意運動に合わせた運動補助装置3での随意運動の補助を実現する。言い換えれば、リハビリテーション支援システム100は、脳活動(脳波)を利用して機械(運動補助装置3)を操作する、ブレイン・マシン・インタフェース(Brain-machine Interface:BMI)の技術を利用して、運動療法によるリハビリテーションを実現する。 By the way, in order to support the above-mentioned rehabilitation, the rehabilitation support system 100 can support the voluntary exercise of the subject 5 with the exercise assisting device 3 when the subject 5 tries to do voluntary exercise. desirable. The rehabilitation support system 100 is an exercise assisting device 3 adapted to the voluntary exercise of the subject 5 by linking the exercise assisting device 3 to the brain wave (brain wave information) of the subject 5 measured by the electroencephalogram measurement system 10. Realize the support of voluntary exercise of In other words, the rehabilitation support system 100 uses a brain-machine interface (BMI) technology to operate a machine (exercise assistance device 3) using brain activity (brain waves) to exercise Realize rehabilitation by therapy.
 対象者5が随意運動を行う際には(つまり、対象者5が随意運動を行う過程で)、脳波に特徴的な変化が生じ得る。つまり、対象者5が随意運動を行おうと企図(想起)した際には、随意運動の対象となる部位に対応する脳領域の活性化が起き得る。このような脳領域の例としては、体性感覚運動皮質が挙げられる。このような脳領域の活性化が起こるタイミングに合わせて、運動補助装置3にて対象者5の随意運動を補助すると、より効果的なリハビリテーションが期待できる。このような脳領域の活性化は、脳波の特徴的な変化として検出され得る。そのため、リハビリテーション支援システム100は、この特徴的な変化が発生するタイミングに合わせて、運動補助装置3にて対象者5の随意運動の補助を実行する。このような特徴的な変化は、随意運動が実際に行われなくても、対象者5が随意運動を想起(image)した際(つまり運動企図中)に生じ得る。つまり、このような脳波の特徴的な変化は、随意運動が実際に行われなくても、対象者5が随意運動を行おうと企図(想起)したことによって対応する脳領域が活性化すれば、生じ得る。そのため、随意運動が不能な状態の対象者5についても、リハビリテーション支援システム100による随意運動の補助が可能である。 When the subject 5 performs a voluntary exercise (that is, in the process of the subject 5 performing a voluntary exercise), characteristic changes in the electroencephalogram may occur. That is, when the subject 5 intends to perform voluntary exercise, activation of a brain region corresponding to a site targeted for voluntary exercise may occur. An example of such a brain region is the somatosensory motor cortex. A more effective rehabilitation can be expected if the exercise assist device 3 assists the voluntary exercise of the subject 5 according to the timing at which such activation of the brain region occurs. Such activation of the brain region can be detected as a characteristic change of the electroencephalogram. Therefore, the rehabilitation support system 100 executes the assistance of the voluntary exercise of the subject 5 with the exercise assistance device 3 in accordance with the timing at which this characteristic change occurs. Such characteristic changes may occur when the subject 5 images a voluntary exercise (that is, during an exercise attempt) even if the voluntary exercise is not actually performed. That is, such characteristic changes of the electroencephalogram can be activated if the corresponding brain region is activated by the intention of the subject 5 to perform the voluntary exercise, even though the voluntary movement is not actually performed. It can occur. Therefore, even for the subject 5 in a state in which voluntary exercise is impossible, the rehabilitation support system 100 can support voluntary exercise.
 脳波測定システム10は、事象関連脱同期(Event-Related Desynchronization:ERD)が生じることで脳波に生じる特定の周波数帯域の強度変化を、特徴的な変化として検出する。本開示でいう「事象関連脱同期」は、随意運動時(随意運動の想起時を含む)に運動野付近で測定される脳波において、特定の周波数帯域のパワーが減少する現象を意味する。本開示でいう、「随意運動時」は、対象者5が随意運動の企図(想起)をしてから随意運動が成功又は失敗するまでの過程を意味する。「事象関連脱同期」は、この随意運動時に、随意運動の企図(想起)をトリガとして、生じ得る。事象関連脱同期によりパワーが減少する周波数帯域は、主としてα波(一例として8Hz以上13Hz未満の周波数帯域)及びβ波(一例として13Hz以上30Hz未満の周波数帯域)である。 The electroencephalogram measurement system 10 detects, as a characteristic change, an intensity change of a specific frequency band that occurs in an electroencephalogram due to occurrence of event-related desynchronization (ERD). The “event-related desynchronization” in the present disclosure means a phenomenon in which the power of a specific frequency band decreases in an electroencephalogram measured in the vicinity of the motor area during voluntary exercise (including recall of voluntary exercise). In the present disclosure, “at the time of voluntary exercise” means a process from the intention of the subject 5 to voluntary exercise (recollection) to the success or failure of the voluntary exercise. The "event-related desynchronization" can occur at the time of this voluntary movement, triggered by the intention (recollection) of the voluntary movement. Frequency bands in which the power decreases due to event-related desynchronization are mainly α waves (for example, a frequency band of 8 Hz to less than 13 Hz) and β waves (for example, a frequency band of 13 Hz to less than 30 Hz).
 このような構成のリハビリテーション支援システム100によれば、医療スタッフの負担を軽減しながらも、対象者5においては、効果的な、運動療法によるリハビリテーションを実現可能となる。また、リハビリテーション支援システム100によれば、例えば、対象者5の随意運動の補助を行う医療スタッフの熟練度等の人的要因によって随意運動の補助のタイミングがばらつくことがなく、リハビリテーションの効果のばらつきが低減される。特に、リハビリテーション支援システム100では、脳波に特徴的な変化が生じたタイミング(つまり、脳領域が実際に活性化したタイミング)で、対象者5の随意運動を補助することができる。このように、リハビリテーション支援システム100では、脳活動のタイミングに合わせた訓練が可能となるから、正しい脳活動の学習及び定着への貢献が期待できる。特に、脳波に特徴的な変化が起きたかどうかは、対象者5及び医療スタッフだけでは判別が困難である。したがって、リハビリテーション支援システム100を用いることで、対象者5又は医療スタッフだけでは実現が難しい効果的なリハビリテーションが可能となる。 According to the rehabilitation support system 100 having such a configuration, it is possible to realize effective rehabilitation by exercise therapy in the target person 5 while reducing the burden on the medical staff. Moreover, according to the rehabilitation support system 100, for example, there is no variation in the timing of assisting voluntary exercise due to human factors such as the skill of the medical staff who assists the voluntary exercise of the subject 5, and the variation of the effect of rehabilitation Is reduced. In particular, in the rehabilitation support system 100, the voluntary movement of the subject 5 can be assisted at the timing at which the characteristic change in the electroencephalogram (that is, the timing at which the brain region was actually activated). As described above, in the rehabilitation support system 100, since training can be performed according to the timing of brain activity, contribution to learning and establishment of correct brain activity can be expected. In particular, it is difficult for the subject 5 and the medical staff alone to determine whether or not a characteristic change has occurred in the electroencephalogram. Therefore, by using the rehabilitation support system 100, effective rehabilitation that is difficult to realize only by the target person 5 or the medical staff is possible.
 ヘッドセット1は、図3A及び図3Bに示すように、本体15と、フレーム17と、電極部11とを備えている。本体15は、箱状であって、内部に信号処理部12と、通信部13と、電池14と、を有している(図2参照)。ヘッドセット1は電池駆動式であって、信号処理部12及び通信部13等の動作用電力が電池14から供給される。 The headset 1 includes a main body 15, a frame 17, and an electrode portion 11, as shown in FIGS. 3A and 3B. The main body 15 is in the form of a box, and includes the signal processing unit 12, the communication unit 13, and the battery 14 inside (see FIG. 2). The headset 1 is battery-powered, and power for operation of the signal processing unit 12 and the communication unit 13 is supplied from the battery 14.
 電極部11は、対象者5の脳波(脳波信号)を採取するための電極であって、例えば、銀-塩化銀電極である。電極部11は、銀、金、又は白金等でもよい。電極部11は、第1電極111と、第2電極112とを有している。図3Bに示すように、対象者5の頭部52の表面に設定された測定箇所51は、第1測定箇所511及び第2測定箇所512を含んでいる。第1電極111は、第1測定箇所511に対応する電極であって、第1測定箇所511上に配置される。第2電極112は、第2測定箇所512に対応する電極であって、第2測定箇所512上に配置される。具体的には、第1測定箇所511及び第2測定箇所512は、頭部52の正中中心部と右耳522の耳珠前点とを結ぶ線上に、正中中心部側(上側)から第1測定箇所511、第2測定箇所512の順に並んで配置されている。 The electrode unit 11 is an electrode for collecting the brain wave (brain wave signal) of the subject 5 and is, for example, a silver-silver chloride electrode. The electrode unit 11 may be silver, gold, platinum or the like. The electrode unit 11 has a first electrode 111 and a second electrode 112. As shown in FIG. 3B, the measurement point 51 set on the surface of the head 52 of the subject 5 includes a first measurement point 511 and a second measurement point 512. The first electrode 111 is an electrode corresponding to the first measurement point 511, and is disposed on the first measurement point 511. The second electrode 112 is an electrode corresponding to the second measurement point 512, and is disposed on the second measurement point 512. Specifically, the first measurement point 511 and the second measurement point 512 are located on the line connecting the center of the center of the head 52 and the point at which the front part of the right ear 522 is located. The measurement points 511 and the second measurement points 512 are arranged in order.
 対象者5が随意運動を行おうと企図(想起)した際には、通常、身体の随意運動を行う部位に対応する運動野にて、特徴的な変化を含む脳波が発生する。そこで、脳波測定システム10は、リハビリテーションの対象である障害部位に対応する運動野付近から採取される脳波を測定対象とする。ここで、左手指に対応する運動野は対象者5の右脳にあり、右手指に対応する運動野は対象者5の左脳にある。そのため、対象者5の左の手指53をリハビリテーションの対象とする場合には、対象者5の頭部52の右側に接触させた電極部11(第1電極111及び第2電極112)にて取得される脳波が、脳波測定システム10での測定対象となる。すなわち、電極部11(第1電極111及び第2電極112)は、図3Bに示すように、対象者5の頭部52の右側表面の一部からなる測定箇所51上に配置される。一例として、国際10-20法において電極記号「C4」で表される位置に電極部11(第1電極111及び第2電極112)が配置される。対象者5の右の手指をリハビリテーションの対象とする場合には、対象者5の頭部52の左側表面の一部からなる測定箇所、一例として、国際10-20法において電極記号「C3」で表される位置に電極部11(第1電極111及び第2電極112)が配置される。 When the subject 5 intends to perform a voluntary exercise (remembering), an electroencephalogram including a characteristic change is usually generated in an exercise area corresponding to a site where the voluntary exercise of the body is to be performed. Therefore, the electroencephalogram measurement system 10 measures an electroencephalogram collected from the vicinity of the motor area corresponding to the injury site that is the target of rehabilitation. Here, the motor area corresponding to the left finger is in the right brain of the subject 5, and the motor area corresponding to the right finger is in the left brain of the subject 5. Therefore, when making the left finger 53 of the subject 5 into the object of rehabilitation, it acquires in the electrode part 11 (the 1st electrode 111 and the 2nd electrode 112) made to contact the right side of the head 52 of the subject 5 The electroencephalogram that is generated is the measurement target in the electroencephalogram measurement system 10. That is, the electrode part 11 (the 1st electrode 111 and the 2nd electrode 112) is arrange | positioned on the measurement location 51 which consists of a part of right side surface of the head 52 of the subject 5 as shown to FIG. 3B. As an example, the electrode portion 11 (the first electrode 111 and the second electrode 112) is disposed at a position represented by the electrode symbol "C4" in the international 10-20 method. When the right finger of the subject 5 is targeted for rehabilitation, the measurement site consisting of a part of the left surface of the head 52 of the subject 5, for example, the electrode symbol "C3" in the international 10-20 method The electrode portion 11 (the first electrode 111 and the second electrode 112) is disposed at the position to be displayed.
 また、ヘッドセット1は、参照電極113と、アース電極114を、更に備えている。参照電極113は、第1電極111及び第2電極112の各々で測定される脳波信号の基準電位を測定するための電極である。参照電極113は、頭部52における左耳521又は右耳522のいずれかの後方位置に配置される。具体的には、参照電極113は、頭部52において第1電極111及び第2電極112が配置されている側の耳の後方位置に配置される。図示例では、第1電極111及び第2電極112は、頭部52の右側表面に配置されているので、参照電極113は、右耳522の後方位置に配置される。アース電極114は、頭部52における左耳521又は右耳522のうち参照電極113が配置されていない方の耳の後方位置に配置される。参照電極113が右耳522の後方位置に配置されるので、アース電極114は、左耳521の後方位置に配置される。参照電極113及びアース電極114の各々は、ヘッドセット1の本体15に対して電線16にて電気的に接続されており、頭部52の表面(頭皮)に貼り付けられる。なお、参照電極113及びアース電極114を配置する位置は、上述したような耳の後方位置ではなく、耳たぶであってもよい。耳の後方位置及び耳たぶは、頭部において脳活動由来の生体電位の影響を受けにくい場所である。つまり、参照電極113及びアース電極114は、頭部において脳活動由来の生体電位の影響を受けにくい場所に配置されることが好ましい。 The headset 1 further includes a reference electrode 113 and a ground electrode 114. The reference electrode 113 is an electrode for measuring a reference potential of an electroencephalogram signal measured by each of the first electrode 111 and the second electrode 112. The reference electrode 113 is disposed at a rear position of either the left ear 521 or the right ear 522 in the head 52. Specifically, the reference electrode 113 is disposed at the head 52 at a position behind the ear on which the first electrode 111 and the second electrode 112 are disposed. In the illustrated example, since the first electrode 111 and the second electrode 112 are disposed on the right surface of the head 52, the reference electrode 113 is disposed at the rear position of the right ear 522. The ground electrode 114 is disposed at the rear of the left ear 521 or the right ear 522 of the head 52 where the reference electrode 113 is not disposed. Since the reference electrode 113 is disposed at the rear position of the right ear 522, the ground electrode 114 is disposed at the rear position of the left ear 521. Each of the reference electrode 113 and the ground electrode 114 is electrically connected to the main body 15 of the headset 1 by the electric wire 16, and is attached to the surface (scalp) of the head 52. The position where the reference electrode 113 and the ground electrode 114 are disposed may be the earlobe instead of the position behind the ear as described above. The posterior position of the ear and the earlobe are places in the head that are less susceptible to biopotentials from brain activity. That is, it is preferable that the reference electrode 113 and the ground electrode 114 be disposed at a position on the head that is not easily influenced by bioelectric potential derived from brain activity.
 信号処理部12は、電極部11に電気的に接続されており、電極部11から入力される脳波信号(電気信号)に対して信号処理を実行し、脳波情報を生成する。脳波信号は、第1電極111の電位と、参照電極113の電位との電位差である電圧信号、及び第2電極112の電位と、参照電極113の電位との電位差である電圧信号と、を含む。つまり、ヘッドセット1は、電極部11にて対象者5の脳の活動電位を測定することで対象者5の脳波を測定し、信号処理部12にて脳波を表す脳波情報を生成する。信号処理部12は、少なくとも脳波信号を増幅する増幅器、及びA/D変換するA/D変換器を含んでおり、増幅後のディジタル形式の脳波信号を、脳波情報として出力する。 The signal processing unit 12 is electrically connected to the electrode unit 11, and performs signal processing on an electroencephalogram signal (electric signal) input from the electrode unit 11 to generate electroencephalogram information. The electroencephalogram signal includes a voltage signal which is a potential difference between the potential of the first electrode 111 and a potential of the reference electrode 113, and a voltage signal which is a potential difference between the potential of the second electrode 112 and a potential of the reference electrode 113. . That is, the headset 1 measures the brain waves of the subject 5 by measuring the action potential of the brain of the subject 5 by the electrode unit 11, and generates the brain wave information representing the brain waves by the signal processing unit 12. The signal processing unit 12 includes at least an amplifier for amplifying an electroencephalogram signal and an A / D converter for A / D conversion, and outputs an electroencephalogram signal in digital form after amplification as electroencephalogram information.
 通信部13は、情報処理装置2との通信機能を有している。通信部13は、少なくとも信号処理部12で生成された脳波情報を情報処理装置2に送信する。本実施形態では、通信部13は、情報処理装置2と双方向に通信可能である。通信部13の通信方式は、例えば、Bluetooth(登録商標)等に準拠した無線通信である。通信部13からは、随時、脳波情報が情報処理装置2に送信される。 The communication unit 13 has a communication function with the information processing device 2. The communication unit 13 transmits at least the electroencephalogram information generated by the signal processing unit 12 to the information processing device 2. In the present embodiment, the communication unit 13 can communicate bi-directionally with the information processing apparatus 2. The communication method of the communication unit 13 is, for example, wireless communication conforming to Bluetooth (registered trademark) or the like. From the communication unit 13, electroencephalogram information is transmitted to the information processing device 2 as needed.
 フレーム17は、馬蹄状(言い換えれば、カチューシャ(Alice band)状)である。つまり、フレーム17は、頭部52に装着された状態において、正中中心部から左耳珠及び右耳珠に向かう第1方向D1に延びる形状である。フレーム17は、第1方向に長い帯状の金属板と、金属板の少なくとも一部を覆う樹脂製のカバーと、で構成されている。フレーム17は、可撓性を有している。このため、フレーム17を撓ませることで、フレーム17の第1方向D1の両端の間隔を広げることが可能である。したがって、フレーム17を頭部52に装着する際には、頭部52の大きさに応じてフレーム17を適宜撓ませることで、フレーム17の第1方向D1の両端間に頭部52を通すことが可能である。 The frame 17 is horseshoe-like (in other words, in the form of an Alice band). That is, the frame 17 has a shape extending in the first direction D1 from the center portion toward the left tragus and the right tragus in a state where the frame 17 is mounted on the head 52. The frame 17 is configured of a strip-shaped metal plate long in the first direction, and a resin cover that covers at least a part of the metal plate. The frame 17 is flexible. Therefore, by bending the frame 17, it is possible to widen the distance between both ends of the frame 17 in the first direction D1. Therefore, when attaching the frame 17 to the head 52, the head 52 is inserted between both ends of the frame 17 in the first direction D1 by appropriately bending the frame 17 according to the size of the head 52. Is possible.
 フレーム17の第1方向D1における中央部には、本体15が取り付けられている。ここで、本体15には、図3Aに示すように、フレーム17を頭部52に装着したときに、本体15が正中中心部に対して適切な位置に配置されているかを確認するための開口部151が設けられている。開口部151は、本体15を第1方向D1及び第2方向D2の両方に交差する(直交する)方向に貫通している。例えば、医療スタッフは、ヘッドセット1を対象者5の頭部52に装着する際に、本体15の開口部151を通して頭部52の正中中心部が視認できる位置に本体15が配置されるように、ヘッドセット1の装着位置を調整することが可能である。 A main body 15 is attached to a central portion of the frame 17 in the first direction D1. Here, as shown in FIG. 3A, when the frame 17 is mounted on the head 52, the main body 15 is an opening for confirming whether the main body 15 is disposed at an appropriate position with respect to the central portion in the center. The part 151 is provided. The opening 151 penetrates the main body 15 in a direction intersecting (orthogonal to) both the first direction D1 and the second direction D2. For example, when the medical staff mounts the headset 1 on the head 52 of the subject 5, the main body 15 is disposed at a position where the central portion of the head 52 can be seen through the opening 151 of the main body 15. , The mounting position of the headset 1 can be adjusted.
 フレーム17の第1方向D1の両端には、それぞれ保持部18が繋がっている。言い換えれば、フレーム17が頭部52に装着された状態において、フレーム17の左耳珠側の一端と、右耳珠側の一端とに、それぞれ保持部18が繋がっている。保持部18は、フレーム17に対して第1方向D1に沿って移動可能に構成されている。つまり、保持部18と、フレーム17の第1方向D1の一端との間の距離は、調整可能である。 Holding portions 18 are connected to both ends of the frame 17 in the first direction D1. In other words, in the state where the frame 17 is attached to the head 52, the holding portion 18 is connected to one end on the left tragus side of the frame 17 and one end on the right tragus side. The holding unit 18 is configured to be movable along the first direction D1 with respect to the frame 17. That is, the distance between the holding portion 18 and one end of the frame 17 in the first direction D1 is adjustable.
 保持部18は、図3Bに示すように、基部18Aと、パッド18Bと、を有している。基部18A及びパッド18Bは、いずれもフレーム17が頭部52に装着された状態において頭部52に沿うように、湾曲している。 The holding portion 18 has a base portion 18A and a pad 18B as shown in FIG. 3B. The base 18A and the pad 18B are both curved along the head 52 when the frame 17 is attached to the head 52.
 基部18Aは、第2方向D2に長い扁平な直方体状であって、フレーム17と繋がっている。基部18Aの第2方向D2の一端(ここでは、頭部52の後頭結節側の一端)は、基部18Aの他の部位と比較して第1方向D1の寸法が大きくなっている。基部18Aのうち頭部52と対向する部位には、面ファスナーが設けられている。 The base 18A is in the form of a flat rectangular parallelepiped elongated in the second direction D2, and is connected to the frame 17. One end of the base 18A in the second direction D2 (here, one end on the occipital node side of the head 52) has a dimension in the first direction D1 larger than that of the other portion of the base 18A. The surface fastener is provided in the part which opposes the head 52 among the base 18A.
 パッド18Bは、第2方向D2に長い扁平な直方体状であって、基部18Aに取り付けられる。パッド18Bは、フレーム17が頭部52に装着された状態で基部18Aと頭部52との間に位置し、頭部52に接触する。パッド18Bは、例えばウレタン樹脂製であって、基部18Aよりも硬度が低い。したがって、パッド18Bは、フレーム17が頭部52に装着された状態において頭部52に接触することにより、ヘッドセット1及び頭部52に挟まれたパッド18Bが変形し、ヘッドセット1から頭部52に加わる力を低減する。 The pad 18B has a flat rectangular parallelepiped shape that is long in the second direction D2, and is attached to the base 18A. The pad 18B is located between the base 18A and the head 52 and in contact with the head 52 with the frame 17 mounted on the head 52. The pad 18B is made of, for example, a urethane resin, and has a hardness lower than that of the base 18A. Therefore, the pad 18B comes into contact with the head 52 when the frame 17 is attached to the head 52, so that the pad 18B sandwiched between the headset 1 and the head 52 is deformed, and the head from the headset 1 is Reduce the force on 52.
 パッド18Bのうち基部18Aと対向する部位には、面ファスナーが貼り付けられている。そして、パッド18Bの面ファスナーを、基部18Aの面ファスナーに結合させることで、パッド18Bが基部18Aに取り付けられる。このように、パッド18Bは、基部18Aに対して着脱可能である。 A surface fastener is attached to a part of the pad 18B facing the base 18A. And the pad 18B is attached to the base 18A by bonding the surface fastener of the pad 18B to the surface fastener of the base 18A. Thus, the pad 18B is removable from the base 18A.
 一対の引掛け部184は、保持部18の第2方向D2の両端にそれぞれ設けられている。引掛け部184は、フック状に形成されており、バンドの一端が引っ掛かるように構成されている。バンドは、頭部52の周方向(第2方向D2)に沿って長い形状であって、弾性を有している。バンドは、その両端をそれぞれ一対の保持部18の前頭部側及び/又は後頭部側の引掛け部184に引っ掛けることにより、頭部52に装着される。バンドを装着することにより、ヘッドセット1が頭部52により強固に固定される。このため、対象者5の姿勢の変化等によってヘッドセット1の位置ずれが生じるのを抑制することができる。 The pair of hooking portions 184 are provided at both ends of the holding portion 18 in the second direction D2. The hooking portion 184 is formed in a hook shape, and one end of the band is configured to be hooked. The band has a long shape along the circumferential direction (second direction D2) of the head 52 and has elasticity. The band is attached to the head 52 by hooking both ends thereof to hooks 184 on the forehead side and / or the occipital side of the pair of holding portions 18, respectively. By mounting the band, the headset 1 is firmly fixed by the head 52. For this reason, it can suppress that position shift of the headset 1 arises by the change of the attitude | position of the subject person 5, etc. FIG.
 フレーム17には、一対の取付部19が更に設けられている。一対の取付部19は、第1方向D1において、本体15を挟んだ両側にそれぞれ設けられている。一対の取付部19のうち少なくとも一方は、第1電極111及び第2電極112を有している。本実施形態では、一対の取付部19のうち対象者5の右耳522側の取付部19が第1電極111及び第2電極112を有している。 The frame 17 is further provided with a pair of attachment portions 19. The pair of attachment portions 19 are provided on both sides of the main body 15 in the first direction D1. At least one of the pair of attachment portions 19 has a first electrode 111 and a second electrode 112. In the present embodiment, the mounting portion 19 on the right ear 522 side of the subject 5 among the pair of mounting portions 19 has the first electrode 111 and the second electrode 112.
 取付部19は、ベース190と、第1ケース191と、第2ケース192と、ハンドル193と、を有している。ベース190は、フレーム17を第2方向D2において挟み込む形状を有している。ベース190は、フレーム17に沿って第1方向D1に移動可能に構成されている。したがって、第1方向D1においてフレーム17に対するベース190の位置を調整することにより、結果として電極部11(第1電極111及び第2電極112)の位置を調整することが可能である。 The mounting portion 19 has a base 190, a first case 191, a second case 192, and a handle 193. The base 190 has a shape that sandwiches the frame 17 in the second direction D2. The base 190 is configured to be movable in the first direction D1 along the frame 17. Therefore, by adjusting the position of the base 190 with respect to the frame 17 in the first direction D1, it is possible to adjust the position of the electrode portion 11 (the first electrode 111 and the second electrode 112) as a result.
 ハンドル193は、ベース190に設けられている。ハンドル193は、ベース190がフレーム17に対して固定された状態と、ベース190がフレーム17に対して移動可能な状態とを択一的に切り替えるために用いられる。具体的には、ハンドル193を締め付けることにより、ベース190がフレーム17に対して固定された状態となり、ハンドル193を緩めることにより、ベース190がフレーム17に対して移動可能な状態となる。 The handle 193 is provided on the base 190. The handle 193 is used to selectively switch between a state in which the base 190 is fixed relative to the frame 17 and a state in which the base 190 is movable relative to the frame 17. Specifically, by tightening the handle 193, the base 190 is fixed to the frame 17. By loosening the handle 193, the base 190 can be moved relative to the frame 17.
 第1ケース191及び第2ケース192は、いずれも楕円形状の底部を有する筒体である。第1ケース191は、第1底部(頭部52と対向する底部)がベース190に取り付けられており、内部に第1電極111及び第2電極112が保持されている。第1電極111及び第2電極112は、いずれも第1端(頭部52と対向する一端)が第1ケース191から突出している。第1電極111及び第2電極112は、いずれも第1ケース191からの突出量を変更できるように、第1ケース191に対して相対的に移動可能に構成されている。第1ケース191には、コイルばねが収納されている。コイルばねは、第1電極111及び第2電極112の第2端と、第1ケース191の第2底部(第1底部と反対側の底部)との間に配置されている。コイルばねの一端は、第1ケース191の底部に固定されている。 Each of the first case 191 and the second case 192 is a cylindrical body having an elliptical bottom. The first case 191 has a first bottom (a bottom facing the head 52) attached to the base 190, and the first electrode 111 and the second electrode 112 are held therein. Each of the first electrode 111 and the second electrode 112 has a first end (one end facing the head 52) protruding from the first case 191. The first electrode 111 and the second electrode 112 are both configured to be movable relative to the first case 191 so that the amount of protrusion from the first case 191 can be changed. A coil spring is accommodated in the first case 191. The coil spring is disposed between the second ends of the first electrode 111 and the second electrode 112 and the second bottom of the first case 191 (the bottom opposite to the first bottom). One end of the coil spring is fixed to the bottom of the first case 191.
 第2ケース192は、第1端(頭部52と対向する一端)が開口しており、第1ケース191よりも頭部52の表面(頭皮)の法線方向から見たときの外形が大きい。第2ケース192は、開口を通して内側に第1ケース191の一部を収納するように、第1ケース191と組み合わされている。第2ケース192は、コイルスプリングが伸縮する方向において、第1位置と第2位置との間で、第1ケース191に対して相対的に移動可能に構成されている。第1位置では、第2ケース192からの第1ケース191の突出量が最小となり、第2位置では、第2ケース192からの第1ケース191の突出量が最大となる。第2ケース192の第2端(第1端と反対側の一端)の内底部には、第1ケース191の第2底部を貫通するシャフトの第1端が固定されている。シャフトの第2端は、第1電極111及び第2電極112に固定されている。したがって、第2ケース192を第1ケース191に対して第1位置と第2位置との間で移動させることにより、第2ケース192及びシャフトの移動に伴って第1電極111及び第2電極112も移動する。つまり、第2ケース192を第1ケース191に対して移動させることにより、第1電極111及び第2電極112の第1ケース191からの突出量を調整することが可能である。 The second case 192 has an open first end (one end facing the head 52), and the outer shape when viewed in the normal direction of the surface (scalp) of the head 52 is larger than that of the first case 191 . The second case 192 is combined with the first case 191 so as to store a part of the first case 191 inside through the opening. The second case 192 is configured to be movable relative to the first case 191 between the first position and the second position in the direction in which the coil spring expands and contracts. In the first position, the amount of projection of the first case 191 from the second case 192 is the smallest, and in the second position, the amount of projection of the first case 191 from the second case 192 is the largest. The first end of the shaft passing through the second bottom of the first case 191 is fixed to the inner bottom of the second end of the second case 192 (the end opposite to the first end). The second end of the shaft is fixed to the first electrode 111 and the second electrode 112. Therefore, by moving the second case 192 between the first position and the second position with respect to the first case 191, the first electrode 111 and the second electrode 112 are moved along with the movement of the second case 192 and the shaft. Move too. That is, by moving the second case 192 with respect to the first case 191, it is possible to adjust the amount of projection of the first electrode 111 and the second electrode 112 from the first case 191.
 さらに、第2ケース192は、第2位置において、第1ケース191に対して第2方向D2に移動可能に構成されている。そして、第2ケース192を第2位置において第2方向D2に移動させることにより、第2ケース192の第1端が第1ケース191の第2底部に引っ掛かる。ここで、第2ケース192を引っ張ることで、第2ケース192を第1位置から第2位置に移動させると、第1電極111及び第2電極112が第1ケース191の内側へと移動してコイルばねが圧縮される。そして、第2ケース192を引っ張る力を解除すると、コイルばねの弾性力により第1電極111及び第2電極112が元の状態に復帰する。一方、上述のように第2ケース192を第1ケース191に引っ掛けた場合、第2ケース192の第2位置から第1位置への移動が規制されるので、コイルばねが圧縮した状態を維持させることができる。つまり、この場合、第1電極111及び第2電極112が第1ケース191の内側へ移動した状態を維持させることができる。 Furthermore, the second case 192 is configured to be movable in the second direction D2 with respect to the first case 191 at the second position. Then, the first end of the second case 192 is hooked on the second bottom of the first case 191 by moving the second case 192 in the second direction D2 at the second position. Here, when the second case 192 is moved from the first position to the second position by pulling the second case 192, the first electrode 111 and the second electrode 112 move to the inside of the first case 191. The coil spring is compressed. Then, when the pulling force of the second case 192 is released, the first electrode 111 and the second electrode 112 return to the original state by the elastic force of the coil spring. On the other hand, when the second case 192 is hooked to the first case 191 as described above, the movement of the second case 192 from the second position to the first position is restricted, so the compressed state of the coil spring is maintained. be able to. That is, in this case, the state in which the first electrode 111 and the second electrode 112 move to the inside of the first case 191 can be maintained.
 ヘッドセット1が対象者5の頭部52に装着された状態では、第1電極111及び第2電極112の各々が頭部52に押されて第1ケース191の内側へ移動した状態に維持される。つまり、第1電極111及び第2電極112の各々は、圧縮されたコイルばねの弾性力によって頭部52の測定箇所51を押している。ヘッドセット1で対象者5の脳波を計測する際、第1電極111及び第2電極112を頭部52の測定箇所51に密着させることが望ましい。そのためにヘッドセット1では、第1電極111及び第2電極112をコイルばねの弾性力で測定箇所51に押し当てることにより、第1電極111及び第2電極112と測定箇所51の密着度を高めている。ここで、第1電極111及び第2電極112が測定箇所51に押し当てられる時間が長くなればなるほど、第1電極111及び第2電極112が押し当てられている測定箇所51に紅斑が生じ易くなる。そして、測定箇所51に紅斑が生じた場合、当該紅斑が持続性の紅斑なのか一時的な紅斑なのかを見極める(評価する)必要がある。持続性の紅斑は、血管の破綻によって赤血球が漏出して生じ、やがて褥瘡になる可能性が高いと考えられる。褥瘡は不可逆的に阻血障害に陥った状態であるので、発生初期には紅斑となって現れることが多い。一方、一時的な紅斑は、真皮深層の微小血管の拡張による反応性充血であって褥瘡ではない。 When the headset 1 is attached to the head 52 of the subject 5, each of the first electrode 111 and the second electrode 112 is pushed by the head 52 and maintained in the state of being moved to the inside of the first case 191. Ru. That is, each of the first electrode 111 and the second electrode 112 pushes the measurement point 51 of the head 52 by the elastic force of the compressed coil spring. When measuring the brain waves of the subject 5 with the headset 1, it is desirable that the first electrode 111 and the second electrode 112 be in close contact with the measurement location 51 of the head 52. Therefore, in the headset 1, the adhesion between the first electrode 111 and the second electrode 112 and the measurement point 51 is enhanced by pressing the first electrode 111 and the second electrode 112 against the measurement point 51 by the elastic force of the coil spring. ing. Here, as the time when the first electrode 111 and the second electrode 112 are pressed against the measurement point 51 becomes longer, erythema tends to occur at the measurement point 51 where the first electrode 111 and the second electrode 112 are pressed. Become. Then, when erythema occurs in the measurement point 51, it is necessary to determine (evaluate) whether the erythema is persistent erythema or temporary erythema. It is considered that persistent erythema is caused by leakage of red blood cells due to the rupture of blood vessels and is likely to be wrinkled over time. Acupuncture and moxibustion are irreversibly obstructive, and often appear as erythema at the early stage of development. On the other hand, temporary erythema is reactive hyperemia due to the dilation of microvessels in the deep dermis and is not wrinkles.
 一般に、持続性の紅斑と一時的な紅斑を簡易的に見分ける方法として、指押し法がある。指押し法は、検査者が紅斑部分を指で3秒押して当該紅斑部分が白っぽく変化するかどうかを見て判定する方法である。紅斑部分が白くなる場合は、可逆性のある皮膚の状態(反応性充血)であって褥瘡ではないと判定でき、白く消退しない場合は持続性の紅斑で褥瘡と判定できる。 In general, there is a finger pressing method as a method of easily identifying persistent erythema and temporary erythema. In the finger pressing method, the examiner presses the erythema portion with a finger for 3 seconds to determine whether the erythema portion changes whitish or not. When the erythema part becomes white, it can be determined that it is a reversible skin condition (reactive hyperemia) and not a wrinkle, and when it does not disappear white, it can be determined as a persistent erythema due to persistent erythema.
 しかしながら、上述のような指押し法では検査者の個人差による判定結果のばらつきが大きいという問題がある。そこで、従来技術で説明したような方法で測定箇所51の紅斑値を測定し、紅斑値に基づいて、当該紅斑が持続性の紅斑なのか一時的な紅斑なのかを判定することが好ましい。ただし、上述したヘッドセット1の装着によって紅斑が生じる測定箇所51に頭髪が生えている場合、例えリハビリテーションを行うためとはいえ、頭髪を剃ることを対象者5に納得させることは難しい。一方、頭髪を剃らずに頭髪の下の頭皮の紅斑値を測定しようとすれば、頭髪の影響で紅斑値の測定精度が著しく低下する可能性がある。したがって、対象者5の測定箇所51に生じる炎症(紅斑)を評価するに当たっては、頭髪を剃らずに測定値(紅斑値)に対する頭髪の影響をできるだけ低減することが望まれている。 However, in the finger pressing method as described above, there is a problem that the variation in the determination result due to the individual difference of the examiner is large. Therefore, it is preferable to measure the erythema value of the measurement point 51 by the method described in the prior art, and to determine whether the erythema is a persistent erythema or a temporary erythema based on the erythema value. However, in the case where hair grows at the measurement point 51 where erythema occurs due to the wearing of the headset 1 described above, it is difficult to convince the object person 5 to shave the hair although it is for rehabilitation. On the other hand, if it is attempted to measure the erythema value of the scalp under the hair without shaving the hair, the measurement accuracy of the erythema value may be significantly reduced due to the influence of the hair. Therefore, in assessing the inflammation (erythema) occurring at the measurement site 51 of the subject 5, it is desirable to reduce the influence of the hair on the measurement value (erythema value) as much as possible without shaving the hair.
 次に、本実施形態の炎症の評価システム(以下、評価システムと略す)6を説明する。評価システム6は、図4に示すように、測定器7で測定された測定値(紅斑値とメラニン値)を用いて患部の炎症を評価する。 Next, an inflammation evaluation system (hereinafter referred to as an evaluation system) 6 according to the present embodiment will be described. As shown in FIG. 4, the evaluation system 6 uses the measured values (erythema value and melanin value) measured by the measuring device 7 to evaluate the inflammation of the affected area.
 本実施形態の評価システム6で使用する測定器7は、プローブ70と、LED駆動回路71と、受光回路72と、制御回路73と、伝送回路74とを備えている。 The measuring instrument 7 used in the evaluation system 6 of the present embodiment includes a probe 70, an LED drive circuit 71, a light receiving circuit 72, a control circuit 73, and a transmission circuit 74.
 プローブ70は、内部に空洞を有する円筒形状のプローブ本体700を有する。プローブ本体700の底面には円形の開口7000が設けられている。プローブ本体700の内部空間に複数(例えば、16個)のLED702と受光部703が収容されている。 The probe 70 has a cylindrical probe body 700 having a cavity inside. A circular opening 7000 is provided at the bottom of the probe body 700. A plurality of (for example, 16) LEDs 702 and light receiving units 703 are accommodated in the internal space of the probe main body 700.
 複数のLED702には、放射光の波長が互いに異なる複数種類のLED、例えば、波長が568nmの緑色光を放射するLEDと、波長が660nmの赤色光を放射するLEDと、波長が880nmの赤外光を放射するLEDとが含まれる。これら3種類のLEDを含む複数のLED702は、プローブ本体700内に設けられている遮光板701の一面(図4における下面)に配置されている。 The plurality of LEDs 702 include a plurality of types of LEDs whose emission light wavelengths are different from each other, for example, an LED that emits green light with a wavelength of 568 nm, an LED that emits red light with a wavelength of 660 nm, and an infrared light with a wavelength of 880 nm And an LED that emits light. The plurality of LEDs 702 including these three types of LEDs are disposed on one surface (the lower surface in FIG. 4) of the light shielding plate 701 provided in the probe main body 700.
 遮光板701は、中央に円形の貫通孔7010を有する円板状に形成されている。遮光板701は、貫通孔7010をプローブ本体700の開口7000に正対させるようにプローブ本体700内に配置されている。 The light shielding plate 701 is formed in a disk shape having a circular through hole 7010 at the center. The light shielding plate 701 is disposed in the probe main body 700 so that the through hole 7010 faces the opening 7000 of the probe main body 700.
 受光部703は、例えば、ガラスレンズ付きのキャンにフォトダイオードチップを収容した光電変換素子である。ただし、受光部703はフォトダイオードチップを有する光電変換素子に限定されず、フォトトランジスタを有する光電変換素子などであってもかまわない。受光部703は、光軸が遮光板701の貫通孔7010の中心を通ってプローブ本体700の開口7000の中心と交わるようにプローブ本体700内に収容されている。 The light receiving unit 703 is, for example, a photoelectric conversion element in which a photodiode chip is accommodated in a can with a glass lens. However, the light receiving portion 703 is not limited to a photoelectric conversion element having a photodiode chip, and may be a photoelectric conversion element having a phototransistor or the like. The light receiving unit 703 is accommodated in the probe main body 700 such that the optical axis intersects the center of the opening 7000 of the probe main body 700 through the center of the through hole 7010 of the light shielding plate 701.
 LED駆動回路71は、複数のLED702のうちで放射光の波長が同一である同種のLED702毎に駆動電流を供給して発光させることができるように構成されている。例えば、LED駆動回路71は、定電流回路とアナログスイッチを有している。アナログスイッチは、同種のLED702と定電流回路との電気的な接続状態を入切する。定電流回路は、アナログスイッチを介して電気的に接続される複数のLED702に定電流を供給する。なお、アナログスイッチの入切は、制御回路73によって制御される。 The LED drive circuit 71 is configured to be able to supply a drive current to emit light for each of the LEDs 702 of the same type whose emitted light has the same wavelength among the plurality of LEDs 702. For example, the LED drive circuit 71 includes a constant current circuit and an analog switch. The analog switch turns on and off the electrical connection between the LED 702 of the same type and the constant current circuit. The constant current circuit supplies a constant current to the plurality of LEDs 702 electrically connected through the analog switch. Note that turning on / off of the analog switch is controlled by the control circuit 73.
 受光回路72は、受光部703に対して順方向の定電圧を印加し、かつ、受光部703に流れる順方向電流の大きさを測定する。さらに、受光回路72は、順方向電流の大きさ(受光部703の受光光量)に対応した電圧値を持つ測定信号を制御回路73に出力する。 The light receiving circuit 72 applies a constant voltage in the forward direction to the light receiving unit 703, and measures the magnitude of the forward current flowing through the light receiving unit 703. Further, the light receiving circuit 72 outputs, to the control circuit 73, a measurement signal having a voltage value corresponding to the magnitude of the forward current (the amount of light received by the light receiving unit 703).
 制御回路73は、例えば、マイクロコントローラで構成される。制御回路73は、LED駆動回路71に対してアナログスイッチを入切させる制御信号と、LED駆動回路71に対して複数のLED702のうち同一の波長の光を放射する複数のLED702を駆動させるように指示する制御信号とを送信する。また、制御回路73は、受光回路72が出力する測定信号をAD変換して取り込み、ディジタル化された測定信号のデータ(測定データ)から各波長毎の光強度を求め、求めた光強度を内蔵のメモリに格納する。さらに、制御回路73は、3種類の光(緑色光、赤色光、赤外光)のうちの緑色光の光強度と赤色光の光強度を用いて紅斑値(ヘモグロビン濃度)を測定し、赤色光の光強度と赤外光の光強度を用いてメラニン値(メラニン色素濃度)を測定する。ただし、制御回路73は、1回当たり約1秒間の測定処理において紅斑値とメラニン値を一度に測定することができる。つまり、本実施形態においては、メラニン値(メラニン色素濃度)が強度値に該当する。 The control circuit 73 is configured of, for example, a microcontroller. The control circuit 73 controls the LED drive circuit 71 to turn on and off the analog switch, and causes the LED drive circuit 71 to drive the plurality of LEDs 702 that emit light of the same wavelength among the plurality of LEDs 702. And transmitting a control signal to instruct. Further, the control circuit 73 AD converts and takes in the measurement signal output from the light receiving circuit 72, obtains the light intensity for each wavelength from data (measurement data) of the digitized measurement signal, and incorporates the obtained light intensity. Store in memory. Furthermore, the control circuit 73 measures the erythema value (hemoglobin concentration) using the light intensity of the green light and the light intensity of the red light of the three types of light (green light, red light, infrared light), The melanin value (melanin pigment concentration) is measured using the light intensity of light and the light intensity of infrared light. However, the control circuit 73 can measure the erythema value and the melanin value at once in a measurement process of about 1 second per time. That is, in the present embodiment, the melanin level (melanin pigment concentration) corresponds to the intensity value.
 伝送回路74は、例えば、RS-232Cなどの汎用のシリアル通信インタフェースを有している。伝送回路74は、制御回路73で測定した紅斑値とメラニン値を含む測定値のデータを、伝送線を介して評価システム6に伝送する。なお、伝送回路74は、伝送線を介して、評価システム6から制御コマンドなどのデータを受信することもできる。ただし、伝送回路74は、例えば、RS-485及びUSB(Universal Serial Bus)などのRS-232C以外のシリアル通信インタフェースを有していてもよいし、パラレル通信インタフェースを有していてもよい。 The transmission circuit 74 has, for example, a general-purpose serial communication interface such as RS-232C. The transmission circuit 74 transmits data of the measurement value including the erythema value and the melanin value measured by the control circuit 73 to the evaluation system 6 through the transmission line. The transmission circuit 74 can also receive data such as a control command from the evaluation system 6 via a transmission line. However, the transmission circuit 74 may have, for example, a serial communication interface other than RS-232C such as RS-485 and USB (Universal Serial Bus), or may have a parallel communication interface.
 上述のような測定器7の具体例としては、皮膚メラニン色素・ヘモグロビン計測器(Courage + Khazaka electronic GmbH社製のMexameter MX18)などがある。この皮膚メラニン色素・ヘモグロビン計測器が測定器7として用いられれば、対象者5の測定箇所51の紅斑値とメラニン値を短時間で測定することができる。ただし、測定器7は、上記皮膚メラニン色素・ヘモグロビン計測器に限定されない。 Specific examples of the measuring device 7 as described above include a skin melanin pigment / hemoglobin measuring device (Mourameter MX18 manufactured by Courage + Khazaka electronic GmbH). If this skin melanin pigment / hemoglobin measuring device is used as the measuring device 7, it is possible to measure the erythema value and the melanin value of the measurement point 51 of the subject 5 in a short time. However, the measuring device 7 is not limited to the above-mentioned skin melanin pigment / hemoglobin measuring device.
 本実施形態の評価システム6は、図4に示すように、取得部60と、評価部61とを備える。評価システム6は、記憶部62と通知部63とを更に備えることが好ましい。 The evaluation system 6 of the present embodiment includes an acquisition unit 60 and an evaluation unit 61 as shown in FIG. The evaluation system 6 preferably further includes a storage unit 62 and a notification unit 63.
 取得部60は、測定器7の伝送回路74との間で伝送線を介したデータ伝送を行うことにより、測定器7から測定値を取得する。つまり、取得部60は、測定器7の伝送回路74が有する通信インタフェースと同一の通信インタフェースを有している。 The acquisition unit 60 performs data transmission with the transmission circuit 74 of the measurement instrument 7 via the transmission line, thereby acquiring a measurement value from the measurement instrument 7. That is, the acquisition unit 60 has the same communication interface as the communication interface of the transmission circuit 74 of the measuring instrument 7.
 評価部61は、取得部60で取得する複数の測定値のうちから所定の条件を満たす測定値を評価候補の測定値として選出する。さらに、評価部61は、1つ以上の評価候補の測定値に基づいて患部(対象者5の頭部52の測定箇所51)の炎症(紅斑)を評価する。 The evaluation unit 61 selects a measurement value that satisfies a predetermined condition from among a plurality of measurement values acquired by the acquisition unit 60 as a measurement value of an evaluation candidate. Furthermore, the evaluation unit 61 evaluates inflammation (erythema) of the affected area (the measurement point 51 of the head 52 of the subject 5) based on the measurement values of one or more evaluation candidates.
 記憶部62は、フラッシュメモリのような電気的に書換可能な不揮発性の半導体メモリで構成されることが好ましい。通知部63は、液晶ディスプレイと、液晶ディスプレイを駆動する駆動回路とを有することが好ましい。通知部63は、評価部61の評価結果を表すメッセージ又は記号などを液晶ディスプレイに表示させることによって評価者に通知する。ただし、通知部63は、ブザー又はスピーカなどの音響デバイスを有し、評価結果を音(ブザー音又は音声メッセージなど)で通知してもかまわない。 The storage unit 62 is preferably configured by an electrically rewritable non-volatile semiconductor memory such as a flash memory. The notification unit 63 preferably includes a liquid crystal display and a drive circuit that drives the liquid crystal display. The notification unit 63 notifies the evaluator of the evaluation result by causing a liquid crystal display to display a message or a symbol representing the evaluation result of the evaluation unit 61. However, the notification unit 63 may have an acoustic device such as a buzzer or a speaker, and may notify the evaluation result by a sound (such as a buzzer or a voice message).
 ここで、取得部60、評価部61並びに記憶部62は、マイクロコントローラのようにコンピュータシステムを1つの半導体チップに集積した半導体部品で構成されてもよい。あるいは、取得部60、評価部61並びに記憶部62は、それぞれ独立した電子回路で構成されてもよい。いずれの構成においても、評価部61は、マイクロプロセッサからなるハードウェアと、マイクロプロセッサによって実行されるプログラムを含むソフトウェアとを有している。 Here, the acquisition unit 60, the evaluation unit 61, and the storage unit 62 may be configured as semiconductor components in which a computer system is integrated in one semiconductor chip like a microcontroller. Alternatively, the acquisition unit 60, the evaluation unit 61, and the storage unit 62 may be configured by independent electronic circuits. In any of the configurations, the evaluation unit 61 has hardware including a microprocessor and software including a program executed by the microprocessor.
 次に、本実施形態の評価システム6の動作(本実施形態の評価方法)について説明する。本実施形態の評価システム6による炎症の評価は、上述したリハビリテーション支援システム100によるリハビリテーションを行った対象者5の頭部52の測定箇所51に対して行われる。 Next, the operation of the evaluation system 6 of the present embodiment (the evaluation method of the present embodiment) will be described. The evaluation of the inflammation by the evaluation system 6 of the present embodiment is performed on the measurement point 51 of the head 52 of the subject 5 who has performed the rehabilitation by the rehabilitation support system 100 described above.
 まず、評価システム6の評価部61は、測定回数(の変数)nを1に初期化する(図5のフローチャートのステップS1)。評価システム6を操作する操作者は、測定器7のプローブ70を対象者5の測定箇所51に接触させて紅斑値とメラニン値を測定する。ただし、操作者は、測定箇所51の頭髪がプローブ70と頭皮との間にできるだけ挟まれないように頭髪を指で除けながら測定することが望ましい。また、操作者は、測定箇所51において操作者が眼で見て紅斑値が最も高いであろうと判断する場所にプローブ70を接触させて測定することが望ましい。ここで、操作者は、1回の測定作業が終わるたびにプローブ70を対象者5の測定箇所51から一旦離した後、再度測定箇所51に接触させて次回の測定作業を開始して紅斑値及びメラニン値を所定回数(本実施形態では7回)測定する。 First, the evaluation unit 61 of the evaluation system 6 initializes (the variable of) the number of measurements n to 1 (step S1 in the flowchart of FIG. 5). The operator operating the evaluation system 6 brings the probe 70 of the measuring instrument 7 into contact with the measurement point 51 of the subject 5 to measure the erythema value and the melanin value. However, it is desirable for the operator to perform measurement while removing the hair with a finger so that the hair of the measurement point 51 is not caught as much as possible between the probe 70 and the scalp. In addition, it is preferable that the operator contact the probe 70 at a measurement point 51 where the operator judges with eyes to judge that the erythema value will be the highest and make measurement. Here, the operator once separates the probe 70 from the measurement location 51 of the subject 5 every time one measurement operation is completed, then contact the measurement location 51 again to start the next measurement operation, and the erythema value And the melanin level is measured a predetermined number of times (7 times in this embodiment).
 ここで、測定器7で測定されるメラニン値は、測定箇所51の頭皮に沈着しているメラニン色素濃度と頭髪に含まれるメラニン色素濃度を合わせた値である。つまり、対象者5の頭髪の色が黒色である場合、メラニン値が高い程、プローブ70と頭部52の測定箇所51との間に挟まれた頭髪の量が多いと推定される。ただし、対象者5の頭髪の色が白色(白髪)である場合、メラニン値が低い程、プローブ70と頭部52の測定箇所51との間に挟まれた頭髪の量が多いと推定される。以下の説明においては、対象者5の頭髪の色を黒色とする。 Here, the melanin level measured by the measuring instrument 7 is a value obtained by combining the concentration of the melanin pigment deposited on the scalp at the measurement point 51 and the concentration of the melanin pigment contained in the hair. That is, when the color of the hair of the subject 5 is black, it is estimated that the higher the melanin value, the greater the amount of hair sandwiched between the probe 70 and the measurement point 51 of the head 52. However, when the color of the hair of subject 5 is white (white hair), it is estimated that the lower the melanin value, the greater the amount of hair sandwiched between the probe 70 and the measurement point 51 of the head 52 . In the following description, the color of the hair of the subject 5 is black.
 評価システム6の取得部60は、測定器7で測定された7回分の測定値(紅斑値及びメラニン値)を測定器7から取得する(図5のフローチャートのステップS2)。評価部61は、取得部60が取得した7回分の測定値F1(Xk,Yk)を記憶部62に記憶させる。ただし、Xkは、1回の測定作業で7回測定されたうちのk回目の紅斑値であり、Ykは、1回の測定作業で7回測定されたうちのk回目のメラニン値である。 The acquiring unit 60 of the evaluation system 6 acquires seven measurement values (erythema value and melanin value) measured by the measuring device 7 from the measuring device 7 (step S2 in the flowchart of FIG. 5). The evaluation unit 61 causes the storage unit 62 to store seven measurement values F 1 (Xk, Yk) acquired by the acquisition unit 60. However, Xk is the k-th erythema value of the 7 measurements performed in one measurement operation, and Y k is the k-th melanin value of the 7 measurements performed in the 1 measurement operation.
 評価部61は、取得部60から7回分の測定値F1(Xk,Yk)を受け取ると、測定回数nをインクリメントし(図5のフローチャートのステップS3)、測定回数nが5回以上か否かを判断する(図5のフローチャートのステップS4)。評価部61は、測定回数nが5回未満であれば、カウントダウンタイマをスタートし(図5のフローチャートのステップS5)、カウントダウンタイマが所定時間(例えば、15分)をカウントアップするまで待機する(図5のフローチャートのステップS6)。 When the evaluation unit 61 receives seven measurement values F 1 (Xk, Yk) from the acquisition unit 60, the evaluation unit 61 increments the number of measurements n (step S3 in the flowchart of FIG. 5). (Step S4 in the flowchart of FIG. 5). If the number of measurements n is less than five, the evaluation unit 61 starts the countdown timer (step S5 in the flowchart of FIG. 5), and waits until the countdown timer counts up a predetermined time (for example, 15 minutes) ( Step S6 of the flowchart of FIG.
 操作者は、評価部61のカウントダウンタイマが所定時間をカウントアップすると、測定器7を用いて対象者5の測定箇所51の紅斑値とメラニン値を7回測定する。評価システム6の取得部60は、測定器7で測定された7回分の測定値を測定器7から取得する(図5のフローチャートのステップS2)。評価部61は、取得部60が取得した7回分の測定値F2(Xk,Yk)を記憶部62に記憶させる。 When the countdown timer of the evaluation unit 61 counts up the predetermined time, the operator measures the erythema value and the melanin value of the measurement point 51 of the subject 5 seven times using the measuring device 7. The acquisition unit 60 of the evaluation system 6 acquires seven measurement values measured by the measuring device 7 from the measuring device 7 (step S2 in the flowchart of FIG. 5). The evaluation unit 61 causes the storage unit 62 to store seven measurement values F 2 (Xk, Yk) acquired by the acquisition unit 60.
 評価部61は、取得部60から7回分の測定値F2(Xk,Yk)を受け取ると、測定回数nをインクリメントし(図5のフローチャートのステップS3)、測定回数nが5回以上か否かを判断する(図5のフローチャートのステップS4)。評価部61は、測定回数nが5回未満であれば、カウントダウンタイマをスタートし(図5のフローチャートのステップS5)、カウントダウンタイマが所定時間をカウントアップするまで待機する(図5のフローチャートのステップS6)。 When the evaluation unit 61 receives seven measurement values F 2 (Xk, Yk) from the acquisition unit 60, the evaluation unit 61 increments the number of measurements n (step S3 in the flowchart of FIG. 5). (Step S4 in the flowchart of FIG. 5). If the number of measurements n is less than five, the evaluation unit 61 starts the countdown timer (step S5 in the flowchart of FIG. 5), and waits until the countdown timer counts up a predetermined time (step in the flowchart of FIG. 5) S6).
 図5のフローチャートのステップS2~ステップS6の処理は、評価の開始から60分が経過するまで15分ごとにくり返される。その結果、評価システム6の記憶部62には、7個×5回=35個の測定値Fi(Xk,Yk)(ただし、i=1~5、k=1~7)が記憶される。 The processes of steps S2 to S6 in the flowchart of FIG. 5 are repeated every 15 minutes until 60 minutes have elapsed from the start of the evaluation. As a result, the storage unit 62 of the evaluation system 6 stores 7 × 5 = 35 measured values F i (X k, Y k) (where i = 1 to 5, k = 1 to 7). .
 続いて、評価部61は、1回目(評価開始直後)から5回目(評価開始から約60分経過後)までの各回毎に、7個の測定値Fi(Xk,Yk)のうちから評価候補の測定値を選出する(図6のフローチャートのステップS7)。つまり、対象者5の頭髪の色が黒色であるので、測定器7のプローブ70と測定箇所51の頭皮との間に挟まれる頭髪の量が多い程、測定値Fi(Xk,Yk)におけるメラニン値Ykが高くなる。したがって、評価部61は、メラニン値Ykが所定の上限値(第1しきい値)Yth以上である測定値Fi(Xk,Yk)を評価の対象(評価候補)から外すことにより、頭髪の影響が相対的に少ないと推定される測定値Fi(Xk,Yk)を用いて炎症を評価することができる。ただし、上限値Ythは、対象者5の測定箇所51の頭皮のメラニン値が高い程、高い値に設定されることが好ましい。 Subsequently, the evaluation unit 61 evaluates from among the seven measured values F i (Xk, Yk) for each time from the first time (immediately after the start of evaluation) to the fifth time (after approximately 60 minutes from the start of evaluation). The candidate measurement values are selected (step S7 in the flowchart of FIG. 6). That is, since the color of the hair of the subject 5 is black, the larger the amount of hair sandwiched between the probe 70 of the measuring instrument 7 and the scalp of the measuring point 51, the more the measured value F i (Xk, Yk) The melanin value Yk becomes high. Therefore, the evaluation unit 61 removes the measured value F i (Xk, Yk) whose melanin value Yk is equal to or higher than the predetermined upper limit (first threshold value) Yth from the evaluation target (evaluation candidate). Inflammation can be assessed using measurements F i (Xk, Yk), which are estimated to have relatively minor effects. However, it is preferable that the upper limit value Yth be set to a higher value as the melanin level of the scalp of the measurement location 51 of the subject 5 is higher.
 図7は、X軸を紅斑値とし、Y軸をメラニン値とした2次元直交座標系に、i回目の7個の測定値Fi(Xk,Yk)をプロットした図である。評価部61は、図7においてX軸に平行な破線で示される上限値Yth以上のメラニン値Ykを有する4つの測定値Fi(X1,Y1)、Fi(X2,Y2)、Fi(X4,Y4)、Fi(X7,Y7)除いた3つの測定値Fi(X3,Y3)、Fi(X5,Y5)、Fi(X6,Y6)を評価候補の測定値に選出する。  FIG. 7 is a diagram in which seven measurement values F i (Xk, Yk) of the i-th are plotted in a two-dimensional orthogonal coordinate system in which the erythema value is taken on the X axis and the melanin value is taken on the Y axis. The evaluation unit 61 determines four measured values F i (X1, Y1), F i (X2, Y2), F i (having a melanin value Yk equal to or higher than an upper limit value Yth indicated by a broken line parallel to the X axis in FIG. 7). Three measurement values F i (X 3, Y 3), F i (X 5, Y 5), F i (X 6, Y 6) excluding X 4, Y 4) and F i (X 7, Y 7) are selected as measurement values of evaluation candidates .
 評価部61は、各回ごとに選出した評価候補の測定値における紅斑値の平均値を算出する(図6のフローチャートのステップS8)。評価部61は、各回の紅斑値の平均値が評価開始時点(ヘッドセット1が頭部52から取り外された時点)からの時間経過とともに減少しているか否かを判定する(図6のフローチャートのステップS9)。図8は、ヘッドセット1が頭部52から取り外された時点からの経過時間(0分、15分、30分、45分、60分)を横軸にとり、紅斑値の平均値を縦軸にとって各回の紅斑値の平均値(以下、平均値と略す)の時間的な変化を表した折れ線グラフを示している。なお、図8において経過時間0分よりも前の時間の平均値は、対象者5がリハビリテーション支援システム100によるリハビリテーションを行う前(事前)に測定された平均値である。 The evaluation unit 61 calculates the average value of the erythema values in the measurement values of the evaluation candidates selected each time (step S8 in the flowchart of FIG. 6). The evaluation unit 61 determines whether the average value of the erythema values at each time decreases with the passage of time from the evaluation start time (when the headset 1 is removed from the head 52) (see the flowchart of FIG. 6). Step S9). In FIG. 8, the horizontal axis represents the elapsed time (0 minutes, 15 minutes, 30 minutes, 45 minutes, 60 minutes) from the time the headset 1 was removed from the head 52, and the average value of erythema values was vertical axis The line graph which represented the time change of the mean value (it abbreviates to an average value hereafter) of the erythema value of each time is shown. In FIG. 8, the average value of the time before the elapsed time of 0 minutes is an average value measured before (in advance) the subject 5 performs rehabilitation by the rehabilitation support system 100.
 評価部61は、各回の平均値が評価開始時点からの時間経過とともに減少していると判定すると、次に、最終回(60分経過後)の平均値と事前の平均値との差の絶対値を所定のしきい値と比較する(図6のフローチャートのステップS10)。評価部61は、最終回の平均値と事前の平均値との差の絶対値がしきい値以下であれば、対象者5の測定箇所51における紅斑が一時的な紅斑であるから、特に問題はない(評価結果OK)と判定する(図6のフローチャートのステップS11)。一方、評価部61は、最終回の平均値と事前の平均値との差の絶対値がしきい値より高ければ、対象者5の測定箇所51における紅斑が持続性の紅斑であるから、問題がある(評価結果NG)と判定する(図6のフローチャートのステップS12)。また、評価部61は、各回の平均値が評価開始時点からの時間経過とともに減少していないと判定した場合も評価結果NGと判定する(図6のフローチャートのステップS9、ステップS12)。最後に、評価部61は、評価結果を通知部63に通知させる(図6のフローチャートのステップS13)。 If the evaluation unit 61 determines that the average value of each time decreases with the lapse of time from the evaluation start time, next, the absolute value of the difference between the final value (after 60 minutes) and the prior average value The value is compared to a predetermined threshold (step S10 of the flowchart of FIG. 6). If the absolute value of the difference between the final average value and the previous average value is equal to or less than the threshold value, the evaluation unit 61 particularly issues a problem because the erythema at the measurement point 51 of the subject 5 is a temporary erythema. It is determined that there is no (evaluation result OK) (step S11 in the flowchart of FIG. 6). On the other hand, if the absolute value of the difference between the final average value and the previous average value is higher than the threshold, the evaluation unit 61 has a problem because the erythema at the measurement point 51 of the subject 5 is persistent erythema. It is determined that there is (evaluation result NG) (step S12 in the flowchart of FIG. 6). The evaluation unit 61 also determines that the evaluation result is NG when it is determined that the average value of each time does not decrease with the lapse of time from the evaluation start time (steps S9 and S12 in the flowchart of FIG. 6). Finally, the evaluation unit 61 notifies the notification unit 63 of the evaluation result (step S13 in the flowchart of FIG. 6).
 評価システム6は、上述のようにして対象者5の測定箇所51に生じた炎症(紅斑)が一時的な紅斑であるか、持続性の紅斑であるかを評価し、その評価結果を通知する。評価結果がNG、すなわち、測定箇所51の紅斑が持続性の紅斑である評価された場合、対象者5に対するリハビリテーションを中止し、対象者5の測定箇所51に生じた紅斑を治療することが望ましい。 The evaluation system 6 evaluates whether the inflammation (erythema) produced at the measurement site 51 of the subject 5 is temporary erythema or persistent erythema as described above, and notifies the evaluation result . If the evaluation result is NG, that is, if the erythema at the measurement point 51 is evaluated as persistent erythema, it is desirable to stop the rehabilitation for the subject 5 and treat the erythema occurring at the measurement point 51 of the subject 5 .
 上述した評価システムの動作(評価部61のマイクロプロセッサがプログラムに従って実行する処理)は一例に過ぎない。また、評価部61(マイクロプロセッサ)が測定箇所51の紅斑に対して最終的な評価を行っているが、評価部61から通知される紅斑値の経時変化に基づいて、作業者が測定箇所51の紅斑に対して最終的な評価を行ってもかまわない。また、評価システム6と同様の機能は、コンピュータシステムに評価方法を実行させるためのプログラムを記録した非一時的記録媒体で具現化されてもよい。 The operation of the evaluation system described above (the process executed by the microprocessor of the evaluation unit 61 in accordance with the program) is merely an example. In addition, although the evaluation unit 61 (microprocessor) performs final evaluation on the erythema of the measurement point 51, the worker measures the measurement point 51 based on the temporal change of the erythema value notified from the evaluation unit 61. Final evaluation may be performed on erythema of Also, the same function as that of the evaluation system 6 may be embodied in a non-temporary recording medium that records a program for causing a computer system to execute the evaluation method.
 また、対象者5の頭髪の色が白色である場合、評価部61は、メラニン値が所定の下限値(第2しきい値)未満である測定値を評価候補から外すことにより、頭髪(白髪)の影響が相対的に少ないと推定される測定値を用いて炎症を評価することができる。ただし、下限値は、対象者5の測定箇所51の頭皮のメラニン値が低い程、低い値に設定されることが好ましい。 In addition, when the color of the hair of the subject 5 is white, the evaluation unit 61 removes the measurement value whose melanin value is less than a predetermined lower limit (second threshold) from the evaluation candidates, thereby making the hair (white hair) Inflammation can be assessed using measurements that are estimated to be relatively insensitive. However, it is preferable that the lower limit value is set to a lower value as the melanin level of the scalp of the measurement point 51 of the subject 5 is lower.
 なお、本実施形態では、対象者5の頭部52に装着される脳活動計測装置として、頭部52に接触された脳波電極(電極部11)によって脳波を計測するように構成されたヘッドセット1を例示したが、脳活動計測装置はヘッドセット1に限定されない。ヘッドセット1以外の脳活動計測装置として、例えば、機能的近赤外分光装置を挙げることができる。機能的近赤外分光装置は、近赤外光を放射する発光装置と、近赤外光を受光して電気信号に変換する光電変換装置とを有している。機能的近赤外分光装置は、発光装置と光電変換装置を頭皮に接触させ、発光装置の近赤外光を脳内に照射し、大脳皮質の脳表に反射する近赤外光(反射光)を光電変換装置で光電変換することにより大脳皮質の脳表の血流状態(脳活動)を計測する。つまり、機能的近赤外分光装置においては、発光装置と光電変換装置で頭部52の測定箇所51が押されることにより、測定箇所51に紅斑が生じる可能性がある。 In the present embodiment, as a brain activity measuring device mounted on the head 52 of the subject 5, a head set configured to measure an electroencephalogram with an electroencephalogram electrode (electrode unit 11) in contact with the head 52 Although 1 is illustrated, the brain activity measuring device is not limited to the headset 1. Examples of brain activity measuring devices other than the headset 1 include, for example, functional near infrared spectroscopy devices. The functional near-infrared spectroscopy device includes a light-emitting device that emits near-infrared light, and a photoelectric conversion device that receives near-infrared light and converts the light into an electrical signal. A functional near infrared spectroscopy device brings a light emitting device and a photoelectric conversion device into contact with the scalp, emits near infrared light of the light emitting device into the brain, and reflects near infrared light (reflected light) reflected on the brain surface of the cerebral cortex The blood flow state (brain activity) of the brain surface of the cerebral cortex is measured by photoelectrically converting the That is, in the functional near infrared spectroscopy device, when the measurement location 51 of the head 52 is pushed by the light emitting device and the photoelectric conversion device, erythema may occur at the measurement location 51.
 上述のように本開示の第1の態様に係る炎症の評価システム(6)は、皮膚に生じる炎症を評価する。第1の態様に係る評価システム(6)は、測定器(7)によって測定される皮膚の測定箇所(51)における紅斑値及び紅斑の色と異なる色の強度値(メラニン値)を含む測定値を取得する取得部(60)を備える。第1の態様に係る評価システム(6)は、取得部(60)で取得する複数の測定値に含まれる紅斑値に基づいて炎症を評価する評価部(61)を備える。評価部(61)は、複数の測定値の各々における強度値(メラニン値)が所定の範囲内に収まっている測定値を評価候補の測定値に選出する。評価部(61)は、評価候補の測定値に含まれる紅斑値に基づいて炎症を評価する。 As described above, the inflammation evaluation system (6) according to the first aspect of the present disclosure evaluates the inflammation that occurs in the skin. The evaluation system (6) according to the first aspect is a measurement value including an erythema value at the measurement point (51) of the skin measured by the measuring instrument (7) and an intensity value (melanin value) different from the color of erythema An acquisition unit (60) for acquiring the The evaluation system (6) according to the first aspect includes an evaluation unit (61) that evaluates inflammation based on erythema values included in the plurality of measurement values acquired by the acquisition unit (60). The evaluation unit (61) selects a measurement value in which the intensity value (melanin value) in each of the plurality of measurement values is within a predetermined range as the measurement value of the evaluation candidate. An evaluation part (61) evaluates inflammation based on the erythema value contained in the measured value of an evaluation candidate.
 第1の態様に係る炎症の評価システム(6)は、強度値(メラニン値)が所定の範囲内でない測定値を評価候補から除外することにより、皮膚に生えている体毛の影響が少ないと推定される紅斑値に基づいて炎症を評価する。その結果、第1の態様に係る炎症の評価システム(6)は、評価の精度低下の抑制を図ることができる。 The inflammation evaluation system (6) according to the first aspect estimates that the influence of body hair growing on the skin is small by excluding measurement values whose intensity value (melanin value) is not within a predetermined range from evaluation candidates. The inflammation is assessed based on the erythema value being As a result, the inflammation evaluation system (6) according to the first aspect can suppress the reduction in the accuracy of the evaluation.
 本開示の第2の態様に係る炎症の評価システム(6)は、第1の態様との組み合わせにより実現され得る。第2の態様に係る評価システム(6)において、評価部(61)は、強度値を第1しきい値及び第1しきい値よりも低い第2しきい値のうちの少なくとも一方のしきい値と比較することが好ましい。評価部(61)は、複数の測定値のうちの強度値が第1しきい値以下、もしくは強度値が第2しきい値以上の測定値を評価候補の測定値に選出することが好ましい。 The inflammation evaluation system (6) according to the second aspect of the present disclosure can be realized by a combination with the first aspect. In the evaluation system (6) according to the second aspect, the evaluation unit (61) determines a threshold value of at least one of a first threshold value and a second threshold value lower than the first threshold value. It is preferable to compare with the value. It is preferable that the evaluation unit (61) select a measurement value having a strength value equal to or less than a first threshold among the plurality of measurement values or a measurement value having a strength value equal to or more than a second threshold as measurement values of evaluation candidates.
 第2の態様に係る評価システム(6)は、体毛の色が黒色の場合と体毛の色が白色の場合のいずれの場合においても評価の精度低下の抑制を図ることができる。 The evaluation system (6) according to the second aspect can suppress the deterioration of the evaluation accuracy in any of the case where the color of body hair is black and the case where the color of body hair is white.
 本開示の第3の態様に係る炎症の評価システム(6)は、第1又は第2の態様との組み合わせにより実現され得る。第3の態様に係る評価システム(6)において、取得部(60)は、所定時間毎に測定器(7)で測定される複数の測定値を取得することが好ましい。評価部(61)は、所定時間毎に取得された複数の測定値から評価候補の測定値を選出することが好ましい。評価部(61)は、評価候補の測定値における紅斑値の時間的な変化に基づいて炎症を評価することが好ましい。 The inflammation evaluation system (6) according to the third aspect of the present disclosure can be realized by the combination with the first or second aspect. In the evaluation system (6) according to the third aspect, the acquisition unit (60) preferably acquires a plurality of measurement values measured by the measuring instrument (7) at predetermined time intervals. It is preferable that an evaluation part (61) selects the measurement value of an evaluation candidate from the several measurement value acquired for every predetermined time. It is preferable that the evaluation unit (61) evaluates the inflammation based on a temporal change of the erythema value in the measurement value of the evaluation candidate.
 第3の態様に係る評価システム(6)は、評価部(61)が評価候補の測定値における紅斑値の時間的な変化に基づいて炎症を評価することにより、炎症による紅斑が一時的な紅斑と持続性の紅斑のいずれに該当するかを評価することができる。 In the evaluation system (6) according to the third aspect, the evaluation unit (61) evaluates the inflammation based on the temporal change of the erythema value in the measurement value of the evaluation candidate, so that the erythema due to inflammation is temporary erythema. It can be evaluated whether it corresponds to any of erythema and persistent erythema.
 本開示の第4の態様に係る炎症の評価システム(6)は、第1~第3の態様のうちのいずれか1つの態様との組み合わせにより実現され得る。第4の態様に係る評価システム(6)において、少なくとも評価候補の測定値に含まれる紅斑値を記憶する記憶部(62)を備えることが好ましい。評価部(61)は、記憶部(62)に記憶した紅斑値に基づいて炎症を評価することが好ましい。 The inflammation evaluation system (6) according to the fourth aspect of the present disclosure can be realized by combination with any one of the first to third aspects. The evaluation system (6) according to the fourth aspect preferably includes a storage unit (62) that stores the erythema value included in at least the measurement value of the evaluation candidate. It is preferable that an evaluation part (61) evaluates inflammation based on the erythema value memorize | stored in the memory | storage part (62).
 第4の態様に係る評価システム(6)は、評価部(61)が記憶部(62)に記憶した紅斑値に基づいて炎症を評価するので、測定値の測定直後に限らず、任意のタイミングで炎症を評価することができる。 The evaluation system (6) according to the fourth aspect evaluates the inflammation based on the erythema value stored in the storage unit (62) by the evaluation unit (61). Inflammation can be assessed.
 本開示の第5の態様に係る評価方法は、皮膚に生じる炎症を評価する評価方法である。第5の態様に係る評価方法は、測定器(7)によって測定される皮膚の測定箇所(51)における紅斑値及び紅斑の色と異なる色の強度値を含む測定値を取得する。第5の態様に係る評価方法は、複数の測定値の各々における強度値(メラニン値)が所定の範囲内に収まっている測定値を評価候補の測定値に選出する。第5の態様に係る評価方法は、評価候補の測定値に含まれる紅斑値に基づいて炎症を評価する。 The evaluation method according to the fifth aspect of the present disclosure is an evaluation method for evaluating inflammation generated in the skin. The evaluation method according to the fifth aspect acquires a measurement value including an intensity value of a color different from the color of the erythema and the color of the erythema at the measurement point (51) of the skin measured by the measuring instrument (7). The evaluation method according to the fifth aspect selects a measurement value in which the intensity value (melanin value) in each of the plurality of measurement values falls within a predetermined range as the measurement value of the evaluation candidate. The evaluation method which concerns on a 5th aspect evaluates inflammation based on the erythema value contained in the measured value of an evaluation candidate.
 第5の態様に係る評価方法は、評価の精度低下の抑制を図ることができる。 The evaluation method which concerns on a 5th aspect can aim at suppression of the precision fall of evaluation.
 本開示の第6の態様に係るプログラムは、コンピュータシステム(評価部61)に、第5の態様に係る評価方法を実行させる。 The program according to the sixth aspect of the present disclosure causes the computer system (evaluation unit 61) to execute the evaluation method according to the fifth aspect.
 第6の態様に係るプログラムは、評価の精度低下の抑制を図ることができる。 The program concerning a 6th mode can aim at control of a fall of accuracy of evaluation.
 本開示の第7の態様に係る非一時的記録媒体は、コンピュータシステムに、第5の態様に係る評価方法を実行させるためのプログラムを記録した、コンピュータシステムで読み取り可能な非一時的記録媒体である。 A non-transitory recording medium according to a seventh aspect of the present disclosure is a non-transitory recording medium readable by a computer system in which a program for causing a computer system to execute the evaluation method according to the fifth aspect is recorded. is there.
 第7の態様に係る非一時的記録媒体は、評価の精度低下の抑制を図ることができる。 The non-temporary recording medium according to the seventh aspect can suppress deterioration in the accuracy of evaluation.
 6 炎症の評価システム
 7 測定器
 51 測定箇所
 60 取得部
 61 評価部
 62 記憶部
6 Inflammation evaluation system 7 Measuring instrument 51 Measurement point 60 Acquisition unit 61 Evaluation unit 62 Storage unit

Claims (7)

  1.  皮膚に生じる炎症を評価する評価システムであって
     測定器によって測定される前記皮膚の測定箇所における紅斑値及び紅斑の色と異なる色の強度値を含む測定値を取得する取得部と、
     前記取得部で取得する複数の前記測定値に含まれる前記紅斑値に基づいて炎症を評価する評価部と
    を備え、
     前記評価部は、複数の前記測定値の各々における前記強度値が所定の範囲内に収まっている測定値を評価候補の測定値に選出し、前記評価候補の測定値に含まれる前記紅斑値に基づいて炎症を評価する
    炎症の評価システム。
    An evaluation system for evaluating inflammation occurring in the skin, an acquisition unit acquiring a measurement value including an intensity value of a color different from the color of the erythema and the color of the erythema at the measurement site of the skin measured by a measuring device;
    And an evaluation unit that evaluates inflammation based on the erythema values included in the plurality of measurement values acquired by the acquisition unit.
    The evaluation unit selects a measurement value in which the intensity value in each of the plurality of measurement values falls within a predetermined range as a measurement value of an evaluation candidate, and the erythema value included in the measurement value of the evaluation candidate Assessment system of inflammation to assess inflammation based.
  2.  前記評価部は、前記強度値を第1しきい値及び前記第1しきい値よりも低い第2しきい値のうちの少なくとも一方のしきい値と比較し、複数の前記測定値のうちの前記強度値が前記第1しきい値以下、もしくは前記強度値が前記第2しきい値以上の前記測定値を前記評価候補の測定値に選出する
    請求項1記載の炎症の評価システム。
    The evaluation unit compares the intensity value to at least one of a first threshold value and a second threshold value lower than the first threshold value, and selects one of a plurality of the measurement values. The inflammation evaluation system according to claim 1, wherein the measurement value having the intensity value equal to or less than the first threshold value or the measurement value having the intensity value equal to or more than the second threshold value is selected as the measurement value of the evaluation candidate.
  3.  前記取得部は、所定時間毎に前記測定器で測定される複数の前記測定値を取得し、
     前記評価部は、前記所定時間毎に取得された複数の前記測定値から前記評価候補の測定値を選出し、前記評価候補の測定値における前記紅斑値の時間的な変化に基づいて炎症を評価する
    請求項1又は2記載の炎症の評価システム。
    The acquisition unit acquires a plurality of the measurement values measured by the measuring device at predetermined time intervals,
    The evaluation unit selects measurement values of the evaluation candidate from a plurality of the measurement values acquired for each predetermined time, and evaluates inflammation based on a temporal change of the erythema value in the measurement values of the evaluation candidate. The evaluation system of inflammation according to claim 1 or 2.
  4.  少なくとも前記評価候補の測定値に含まれる前記紅斑値を記憶する記憶部を備え、
     前記評価部は、前記記憶部に記憶した前記紅斑値に基づいて炎症を評価する
    請求項1~3のいずれか1項に記載の炎症の評価システム。
    A storage unit configured to store the erythema value included in at least the measurement value of the evaluation candidate;
    The inflammation evaluation system according to any one of claims 1 to 3, wherein the evaluation unit evaluates inflammation based on the erythema value stored in the storage unit.
  5.  皮膚に生じる炎症を評価する評価方法であって
     測定器によって測定される前記皮膚の測定箇所における紅斑値及び紅斑の色と異なる色の強度値を含む測定値を取得し、
     複数の前記測定値の各々における前記強度値が所定の範囲内に収まっている測定値を評価候補の測定値に選出し、前記評価候補の測定値に含まれる前記紅斑値に基づいて炎症を評価する評価方法。
    It is an evaluation method for evaluating the inflammation that occurs in the skin, and acquires a measurement value including an erythema value at the measurement site of the skin measured by a measuring instrument and an intensity value of a color different from the color of the erythema,
    A measurement value in which the intensity value in each of the plurality of measurement values falls within a predetermined range is selected as a measurement value of an evaluation candidate, and inflammation is evaluated based on the erythema value included in the measurement value of the evaluation candidate How to evaluate
  6.  コンピュータシステムに、請求項5に記載の評価方法を実行させるためのプログラム。 A program for causing a computer system to execute the evaluation method according to claim 5.
  7.  コンピュータシステムに、請求項5記載の評価方法を実行させるためのプログラムを記録した、コンピュータシステムに読み取り可能な非一時的記録媒体。 A non-transitory recording medium readable by a computer system, comprising a program for making the computer system execute the evaluation method according to claim 5.
PCT/JP2018/038931 2017-10-20 2018-10-19 Inflammation evaluation system, evaluation method, program, and non-transient recording medium WO2019078327A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019549357A JP6917600B2 (en) 2017-10-20 2018-10-19 Inflammation assessment system, program, non-temporary recording medium

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017204092 2017-10-20
JP2017-204092 2017-10-20

Publications (1)

Publication Number Publication Date
WO2019078327A1 true WO2019078327A1 (en) 2019-04-25

Family

ID=66172930

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2018/038931 WO2019078327A1 (en) 2017-10-20 2018-10-19 Inflammation evaluation system, evaluation method, program, and non-transient recording medium

Country Status (2)

Country Link
JP (1) JP6917600B2 (en)
WO (1) WO2019078327A1 (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423736A (en) * 1981-10-13 1984-01-03 Purdue Research Foundation Method for evaluation of erythema utilizing skin reflectance measurements
US5016173A (en) * 1989-04-13 1991-05-14 Vanguard Imaging Ltd. Apparatus and method for monitoring visually accessible surfaces of the body
US20050030372A1 (en) * 2003-04-08 2005-02-10 Byungjo Jung Method and apparatus for characterization of chromophore content and distribution in skin using cross-polarized diffuse reflectance imaging
US20100140461A1 (en) * 2006-12-13 2010-06-10 Georgia Tech Research Corporation Systems and methods for real time multispectral imaging
WO2014002255A1 (en) * 2012-06-29 2014-01-03 株式会社 東芝 Health management support device, method and program
WO2015146164A1 (en) * 2014-03-28 2015-10-01 独立行政法人放射線医学総合研究所 Prediction device for skin change from radiation exposure, and verification device
JP2015198909A (en) * 2014-04-08 2015-11-12 花王株式会社 Skin classification method, recommendation method of cosmetic, and skin classification card
JP2016107096A (en) * 2014-12-05 2016-06-20 株式会社リコー Random forest based erythema classification for psoriasis
JP2016518885A (en) * 2013-03-19 2016-06-30 シュナイダー ハーラルト Evaluation method of erythema

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423736A (en) * 1981-10-13 1984-01-03 Purdue Research Foundation Method for evaluation of erythema utilizing skin reflectance measurements
US5016173A (en) * 1989-04-13 1991-05-14 Vanguard Imaging Ltd. Apparatus and method for monitoring visually accessible surfaces of the body
US20050030372A1 (en) * 2003-04-08 2005-02-10 Byungjo Jung Method and apparatus for characterization of chromophore content and distribution in skin using cross-polarized diffuse reflectance imaging
US20100140461A1 (en) * 2006-12-13 2010-06-10 Georgia Tech Research Corporation Systems and methods for real time multispectral imaging
WO2014002255A1 (en) * 2012-06-29 2014-01-03 株式会社 東芝 Health management support device, method and program
JP2016518885A (en) * 2013-03-19 2016-06-30 シュナイダー ハーラルト Evaluation method of erythema
WO2015146164A1 (en) * 2014-03-28 2015-10-01 独立行政法人放射線医学総合研究所 Prediction device for skin change from radiation exposure, and verification device
JP2015198909A (en) * 2014-04-08 2015-11-12 花王株式会社 Skin classification method, recommendation method of cosmetic, and skin classification card
JP2016107096A (en) * 2014-12-05 2016-06-20 株式会社リコー Random forest based erythema classification for psoriasis

Also Published As

Publication number Publication date
JP6917600B2 (en) 2021-08-11
JPWO2019078327A1 (en) 2020-10-22

Similar Documents

Publication Publication Date Title
JP6200003B2 (en) Electrode arrangement and installation method
US10835179B2 (en) Headset for bio-signals acquisition
US10980480B2 (en) Connection quality assessment for EEG electrode arrays
JP7033614B6 (en) Measurement of electrical activity
JP6254281B2 (en) EEG measurement and brain stimulation system
JP2012110536A (en) Wake-up assisting apparatus and wake-up assisting method
JP2019076712A (en) Electroencephalograph and electroencephalogram measurement system
US20200315486A1 (en) Electroencephalogram measurement system, rehabilitation support system, method for controlling the electroencephalogram measurement system, program, and non-transitory storage medium
JP4505617B2 (en) Rehabilitation support device
JP7024151B2 (en) EEG measurement system, EEG measurement method, program, and non-temporary recording medium
EP3229677B1 (en) Headset for bio-signals acquisition
KR101315128B1 (en) Method evaluating human homeostasis by measuring multidimensional biomedical signals
AU2022221742A1 (en) Apparatus, systems and methods for monitoring symptoms of neurological conditions
JP6917600B2 (en) Inflammation assessment system, program, non-temporary recording medium
JP6935660B2 (en) Evaluation system, evaluation method, program, and non-temporary recording medium for brain activity measuring device
KR20100048741A (en) Real time psychophysiology-health monitering system using eyeglass
WO2019168500A1 (en) Connection quality assessment for eeg electrode arrays
KR20150122936A (en) Trigger point detection system and method of pain patient's by electric dermal response measuring signal and applied pressure stimulation signal using algometry
JP6960619B2 (en) EEG judgment system
WO2019078323A1 (en) Brain wave measurement system, brain wave measurement method, program, and non-transitory recording medium
JP7219892B2 (en) headset
JP2019076716A (en) Stimulation system and rehabilitation support system

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18868170

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2019549357

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18868170

Country of ref document: EP

Kind code of ref document: A1